DE635692C
(en)
|
|
1936-09-22 |
Herbert Zadow |
Medical syringe
|
US1655158A
(en)
|
1926-09-08 |
1928-01-03 |
Radium Emanation Corp |
Instrument for implanting radon seeds
|
FR640907A
(en)
|
1927-06-25 |
1928-07-24 |
|
Automatic flow limiter
|
US2168437A
(en)
|
1935-04-10 |
1939-08-08 |
Kenneth O Buercklin |
Injection device
|
US2110208A
(en)
|
1937-02-12 |
1938-03-08 |
U S Standard Products Company |
Antigen preparations
|
US2531724A
(en)
*
|
1948-09-20 |
1950-11-28 |
Edmund D Cevasco |
Infant bath mat
|
US2643653A
(en)
|
1951-07-19 |
1953-06-30 |
Heidrich John |
Pill injector
|
US3016895A
(en)
|
1958-08-01 |
1962-01-16 |
Pan American Lab Inc |
Injector for subcutaneous implantation of solids
|
US3025991A
(en)
|
1960-05-23 |
1962-03-20 |
Carron Products Co |
Bottle stopper
|
BE634668A
(en)
|
1962-07-11 |
|
|
|
GB1049104A
(en)
|
1963-05-11 |
1966-11-23 |
Prodotti Antibiotici Spa |
Pharmaceutical compositions for oral or parenteral administration comprising tetracycline antibiotics
|
US3122162A
(en)
|
1963-06-20 |
1964-02-25 |
Asa D Sands |
Flow control device
|
US3523296A
(en)
|
1967-04-25 |
1970-08-04 |
Hellige & Co Gmbh F |
Portable antenna
|
US3538916A
(en)
|
1968-12-19 |
1970-11-10 |
Joseph S Wiles |
Injection pistol
|
BE744162A
(en)
|
1969-01-16 |
1970-06-15 |
Fuji Photo Film Co Ltd |
ENCAPSULATION PROCESS
|
US3620216A
(en)
|
1969-06-25 |
1971-11-16 |
Abbott Lab |
Implant trocar
|
US3632768A
(en)
|
1969-10-02 |
1972-01-04 |
Upjohn Co |
Therapeutic composition and method for treating infections with actinospectacin
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
DE2010115A1
(en)
|
1970-03-04 |
1971-09-16 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Process for the production of micro-granules
|
US3625214A
(en)
|
1970-05-18 |
1971-12-07 |
Alza Corp |
Drug-delivery device
|
US3669104A
(en)
|
1970-06-15 |
1972-06-13 |
Pfizer |
Implant gun
|
US3732865A
(en)
|
1971-01-13 |
1973-05-15 |
Alza Corp |
Osmotic dispenser
|
US4034756A
(en)
|
1971-01-13 |
1977-07-12 |
Alza Corporation |
Osmotically driven fluid dispenser
|
US3995631A
(en)
|
1971-01-13 |
1976-12-07 |
Alza Corporation |
Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
|
US4211771A
(en)
|
1971-06-01 |
1980-07-08 |
Robins Ronald K |
Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
|
US3766915A
(en)
|
1971-12-21 |
1973-10-23 |
Illinois Tool Works |
Plastic needle holder
|
JPS523342B2
(en)
|
1972-01-26 |
1977-01-27 |
|
|
BE795516A
(en)
|
1972-02-17 |
1973-08-16 |
Ciba Geigy |
PREPARATIONS OF OILY AND INJECTABLE PEPTIDES AND PROCESS FOR THEIR PREPARATION
|
US3797492A
(en)
|
1972-12-27 |
1974-03-19 |
Alza Corp |
Device for dispensing product with directional guidance member
|
US3995632A
(en)
|
1973-05-04 |
1976-12-07 |
Alza Corporation |
Osmotic dispenser
|
GB1413186A
(en)
|
1973-06-27 |
1975-11-12 |
Toyo Jozo Kk |
Process for encapsulation of medicaments
|
DE2528516A1
(en)
|
1974-07-05 |
1976-01-22 |
Sandoz Ag |
NEW GALENIC PREPARATION
|
JPS523653A
(en)
|
1975-06-27 |
1977-01-12 |
Fuji Photo Film Co Ltd |
Process for producing fine polymer particles
|
US3987790A
(en)
|
1975-10-01 |
1976-10-26 |
Alza Corporation |
Osmotically driven fluid dispenser
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
US4078060A
(en)
|
1976-05-10 |
1978-03-07 |
Richardson-Merrell Inc. |
Method of inducing an estrogenic response
|
US4203439A
(en)
|
1976-11-22 |
1980-05-20 |
Alza Corporation |
Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
|
US4111202A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for the controlled and delivery of agent over time
|
US4111203A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system with means for improving delivery kinetics of system
|
US4111201A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for delivering selected beneficial agents having varying degrees of solubility
|
US4105030A
(en)
|
1977-01-03 |
1978-08-08 |
Syntex (U.S.A.) Inc. |
Implant apparatus
|
USD258837S
(en)
*
|
1977-10-17 |
1981-04-07 |
Gambro Dialysatoren Gmbh And Co. Kg |
Dialyzer cartridge
|
USD259458S
(en)
*
|
1978-06-09 |
1981-06-09 |
Fuller Charles R |
Support pad for an infant
|
US4223674A
(en)
|
1978-06-29 |
1980-09-23 |
Arthur J. McIntosh |
Implant gun
|
US4243030A
(en)
|
1978-08-18 |
1981-01-06 |
Massachusetts Institute Of Technology |
Implantable programmed microinfusion apparatus
|
US4221882A
(en)
|
1979-01-31 |
1980-09-09 |
Exxon Research & Engineering Co. |
High impact melt-flowable dual continuum melt mixed polymer blends of polypropylene, polyethylene, and ethylene-propylene rubber
|
US4305927A
(en)
|
1979-02-05 |
1981-12-15 |
Alza Corporation |
Method for the management of intraocular pressure
|
US4373527B1
(en)
|
1979-04-27 |
1995-06-27 |
Univ Johns Hopkins |
Implantable programmable medication infusion system
|
US4310516A
(en)
|
1980-02-01 |
1982-01-12 |
Block Drug Company Inc. |
Cosmetic and pharmaceutical vehicle thickened with solid emulsifier
|
US4384975A
(en)
|
1980-06-13 |
1983-05-24 |
Sandoz, Inc. |
Process for preparation of microspheres
|
AU546785B2
(en)
|
1980-07-23 |
1985-09-19 |
Commonwealth Of Australia, The |
Open-loop controlled infusion of diabetics
|
US4350271A
(en)
|
1980-08-22 |
1982-09-21 |
Alza Corporation |
Water absorbing fluid dispenser
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
US4376118A
(en)
|
1980-10-06 |
1983-03-08 |
Miles Laboratories, Inc. |
Stable nonaqueous solution of tetracycline salt
|
US4451253A
(en)
|
1980-12-18 |
1984-05-29 |
Harman Sherman M |
Means and method for administering medicinals
|
US4340054A
(en)
|
1980-12-29 |
1982-07-20 |
Alza Corporation |
Dispenser for delivering fluids and solids
|
US4444498A
(en)
*
|
1981-02-27 |
1984-04-24 |
Bentley Laboratories |
Apparatus and method for measuring blood oxygen saturation
|
US4455145A
(en)
|
1981-07-10 |
1984-06-19 |
Alza Corporation |
Dispensing device with internal drive
|
USD271990S
(en)
*
|
1981-09-17 |
1983-12-27 |
Arthur W. Pulfer |
Baby bath
|
US4474572A
(en)
|
1981-09-29 |
1984-10-02 |
Syntex (U.S.A.) Inc. |
Implanting device and implant magazine
|
GB2112730B
(en)
|
1981-09-30 |
1985-12-18 |
Nat Res Dev |
Encapsulated particles
|
AU561343B2
(en)
|
1981-10-19 |
1987-05-07 |
Genentech Inc. |
Human immune interferon by recombinant dna
|
EP0079143A3
(en)
|
1981-10-20 |
1984-11-21 |
Adnovum Ag |
Pseudoplastic gel transfer
|
DE3273597D1
(en)
|
1981-11-28 |
1986-11-06 |
Sunstar Kk |
Pharmaceutical composition containing interferon in stable state
|
US5004689A
(en)
|
1982-02-22 |
1991-04-02 |
Biogen, Massachusetts |
DNA sequences, recombinant DNA molecules and processes for producing human gamma interferon-like polypeptides in high yields
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4455143A
(en)
|
1982-03-22 |
1984-06-19 |
Alza Corporation |
Osmotic device for dispensing two different medications
|
US6936694B1
(en)
|
1982-05-06 |
2005-08-30 |
Intermune, Inc. |
Manufacture and expression of large structural genes
|
DE3220116A1
(en)
|
1982-05-28 |
1983-12-01 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
MICROBIOLOGICALLY MANUFACTURED (ALPHA) AND SS INTERFERONES, DNA SEQUENCES CODING FOR THESE INTERFERONES, MICROORGANISMS CONTAINING THIS GENETIC INFORMATION, AND METHOD FOR THE PRODUCTION THEREOF
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
US4753651A
(en)
|
1982-08-30 |
1988-06-28 |
Alza Corporation |
Self-driven pump
|
US4966843A
(en)
|
1982-11-01 |
1990-10-30 |
Cetus Corporation |
Expression of interferon genes in Chinese hamster ovary cells
|
US4552561A
(en)
|
1982-12-23 |
1985-11-12 |
Alza Corporation |
Body mounted pump housing and pump assembly employing the same
|
US4673405A
(en)
|
1983-03-04 |
1987-06-16 |
Alza Corporation |
Osmotic system with instant drug availability
|
GB2138298B
(en)
|
1983-04-21 |
1986-11-05 |
Hundon Forge Ltd |
Pellet implanter
|
US4639244A
(en)
|
1983-05-03 |
1987-01-27 |
Nabil I. Rizk |
Implantable electrophoretic pump for ionic drugs and associated methods
|
US4783337A
(en)
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
US4765989A
(en)
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
DE3320583A1
(en)
|
1983-06-08 |
1984-12-13 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
NEW GALENIC PREPARATION FORMS OF ORAL ANTIDIABETICS AND METHOD FOR THE PRODUCTION THEREOF
|
JPS6058915A
(en)
|
1983-09-12 |
1985-04-05 |
Fujisawa Pharmaceut Co Ltd |
Lipid microcapsule preparation containing medicament
|
US4594108A
(en)
|
1983-09-19 |
1986-06-10 |
The Dow Chemical Company |
Highly pseudoplastic polymer solutions
|
US5385738A
(en)
|
1983-10-14 |
1995-01-31 |
Sumitomo Pharmaceuticals Company, Ltd. |
Sustained-release injection
|
US4923805A
(en)
|
1983-11-02 |
1990-05-08 |
Integrated Genetics, Inc. |
Fsh
|
US5639639A
(en)
|
1983-11-02 |
1997-06-17 |
Genzyme Corporation |
Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
|
US4840896A
(en)
|
1983-11-02 |
1989-06-20 |
Integrated Genetics, Inc. |
Heteropolymeric protein
|
US4855238A
(en)
|
1983-12-16 |
1989-08-08 |
Genentech, Inc. |
Recombinant gamma interferons having enhanced stability and methods therefor
|
MX9203641A
(en)
|
1983-12-16 |
1992-07-01 |
Genentech Inc |
RECOMBINANT GAMMA INTERFERONS THAT HAVE IMPROVED STABILITY AND BIOTECHNOLOGICAL METHODS FOR THEIR OBTAINING.
|
US4851228A
(en)
|
1984-06-20 |
1989-07-25 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic
|
US5120832A
(en)
|
1984-08-27 |
1992-06-09 |
Genentech, Inc. |
Distinct family of human leukocyte interferons
|
US5231176A
(en)
|
1984-08-27 |
1993-07-27 |
Genentech, Inc. |
Distinct family DNA encoding of human leukocyte interferons
|
US4927687A
(en)
|
1984-10-01 |
1990-05-22 |
Biotek, Inc. |
Sustained release transdermal drug delivery composition
|
US5411951A
(en)
|
1984-10-04 |
1995-05-02 |
Monsanto Company |
Prolonged release of biologically active somatotropin
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
FI90990C
(en)
|
1984-12-18 |
1994-04-25 |
Boehringer Ingelheim Int |
Recombinant DNA molecule, transformed host organism, and method for producing interferon
|
US4655462A
(en)
|
1985-01-07 |
1987-04-07 |
Peter J. Balsells |
Canted coiled spring and seal
|
US4820267A
(en)
|
1985-02-19 |
1989-04-11 |
Endocon, Inc. |
Cartridge injector for pellet medicaments
|
JPS61189230A
(en)
|
1985-02-19 |
1986-08-22 |
Nippon Kayaku Co Ltd |
Etoposide preparation
|
US4609374A
(en)
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
US4885166A
(en)
|
1985-06-11 |
1989-12-05 |
Ciba-Geigy Corporation |
Hybrid interferons
|
US4845196A
(en)
|
1985-06-24 |
1989-07-04 |
G. D. Searle & Co. |
Modified interferon gammas
|
US4847079A
(en)
|
1985-07-29 |
1989-07-11 |
Schering Corporation |
Biologically stable interferon compositions comprising thimerosal
|
IE59361B1
(en)
|
1986-01-24 |
1994-02-09 |
Akzo Nv |
Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
|
DE3607835A1
(en)
|
1986-03-10 |
1987-09-24 |
Boehringer Ingelheim Int |
HYBRID INTERFERONS, THEIR USE AS MEDICINAL PRODUCTS AND AS INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF ANTIBODIES AND THE USE THEREOF AND METHOD FOR THEIR PRODUCTION
|
DE3608503C2
(en)
|
1986-03-14 |
1994-09-01 |
Stopinc Ag |
Process for automatically casting a strand of a continuous caster
|
US4865845A
(en)
|
1986-03-21 |
1989-09-12 |
Alza Corporation |
Release rate adjustment of osmotic or diffusional delivery devices
|
US4737437A
(en)
|
1986-03-27 |
1988-04-12 |
East Shore Chemical Co. |
Light sensitive diazo compound, composition and method of making the composition
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
US6849708B1
(en)
|
1986-05-05 |
2005-02-01 |
The General Hospital Corporation |
Insulinotropic hormone and uses thereof
|
US7138486B2
(en)
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
US4755180A
(en)
|
1986-06-16 |
1988-07-05 |
Alza Corporation |
Dosage form comprising solubility regulating member
|
DE3636123A1
(en)
|
1986-10-23 |
1988-05-05 |
Rentschler Arzneimittel |
ORAL ADMINISTRATIVE PREPARATIONS CONTAINING SINGLE DOSE FROM 10 TO 240 MG DIHYDROPYRIDINE
|
CA1320905C
(en)
|
1986-11-06 |
1993-08-03 |
Joseph M. Cummins |
Treatment of immuno-resistant disease
|
ZA878295B
(en)
|
1986-11-06 |
1988-05-03 |
Amarillo Cell Culture Co. Inc. |
Treatment of immuno-resistant disease
|
DE3642096A1
(en)
|
1986-12-10 |
1988-06-16 |
Boehringer Ingelheim Int |
HORSE (GAMMA) INTERFERON
|
US4871094A
(en)
|
1986-12-31 |
1989-10-03 |
Alcon Laboratories, Inc. |
Means and method for dispensing substances
|
US5371089A
(en)
|
1987-02-26 |
1994-12-06 |
Senetek, Plc |
Method and composition for ameliorating the adverse effects of aging
|
FR2616665A2
(en)
|
1987-03-16 |
1988-12-23 |
Denance Raymond |
Stabiliser adaptor for hypodermic needle, for adjusting penetration as a function of the angle of attack, formed from a needle guard
|
US4994028A
(en)
|
1987-03-18 |
1991-02-19 |
Endocon, Inc. |
Injector for inplanting multiple pellet medicaments
|
US4834708A
(en)
|
1987-03-31 |
1989-05-30 |
George Pillari |
Puncture needle assembly
|
US5278151A
(en)
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
JPH0720866B2
(en)
|
1987-05-15 |
1995-03-08 |
三生製薬株式会社 |
Transdermal preparation containing eperisone or tolperisone or their salts
|
US4940465A
(en)
|
1987-05-27 |
1990-07-10 |
Felix Theeuwes |
Dispenser comprising displaceable matrix with solid state properties
|
US4892778A
(en)
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
US5023088A
(en)
|
1987-06-25 |
1991-06-11 |
Alza Corporation |
Multi-unit delivery system
|
US5938654A
(en)
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US4874388A
(en)
|
1987-06-25 |
1989-10-17 |
Alza Corporation |
Multi-layer delivery system
|
US4915949A
(en)
|
1987-07-13 |
1990-04-10 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
ATE86484T1
(en)
|
1987-08-08 |
1993-03-15 |
Akzo Nv |
CONTRACEPTIVE IMPLANT.
|
DE3867759D1
(en)
|
1987-08-18 |
1992-02-27 |
Akzo Nv |
INJECTION DEVICE FOR AN IMPLANT.
|
US4915954A
(en)
|
1987-09-03 |
1990-04-10 |
Alza Corporation |
Dosage form for delivering a drug at two different rates
|
US5756450A
(en)
|
1987-09-15 |
1998-05-26 |
Novartis Corporation |
Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
|
US4886668A
(en)
|
1987-09-24 |
1989-12-12 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic pump
|
GB8723846D0
(en)
|
1987-10-10 |
1987-11-11 |
Danbiosyst Ltd |
Bioadhesive microsphere drug delivery system
|
AU2810189A
(en)
|
1987-10-30 |
1989-05-23 |
Stolle Research & Development Corporation |
Low residual solvent microspheres and microencapsulation process
|
US4917895A
(en)
|
1987-11-02 |
1990-04-17 |
Alza Corporation |
Transdermal drug delivery device
|
US4934666A
(en)
|
1988-04-25 |
1990-06-19 |
Peter J. Balsells |
Coiled spring electromagnetic shielding gasket
|
US4961253A
(en)
|
1988-04-25 |
1990-10-09 |
Peter J. Balsells |
Manufacturing method for canted-coil spring with turn angle and seal
|
US5108078A
(en)
|
1988-04-25 |
1992-04-28 |
Peter J. Balsells |
Canted-coil spring loaded while in a cavity
|
US5203849A
(en)
|
1990-03-20 |
1993-04-20 |
Balsells Peter J |
Canted coil spring in length filled with an elastomer
|
US4915366A
(en)
|
1988-04-25 |
1990-04-10 |
Peter J. Balsells |
Outside back angle canted coil spring
|
US4974821A
(en)
|
1988-04-25 |
1990-12-04 |
Peter J. Balsells |
Canted-coil spring with major axis radial loading
|
US4964204A
(en)
|
1988-04-25 |
1990-10-23 |
Peter J. Balsells |
Method for making a garter-type axially-resilient coil spring
|
US4830344A
(en)
|
1988-04-25 |
1989-05-16 |
Peter J. Balsells |
Canted-coil spring with turn angle and seal
|
US5072070A
(en)
|
1989-12-01 |
1991-12-10 |
Peter J. Balsells |
Device for sealing electromagnetic waves
|
US5160122A
(en)
|
1990-03-20 |
1992-11-03 |
Peter J. Balsells |
Coil spring with an elastomer having a hollow coil cross section
|
US5117066A
(en)
|
1988-04-25 |
1992-05-26 |
Peter J. Balsells |
Retaining and locking electromagnetic gasket
|
US4893795A
(en)
|
1988-08-15 |
1990-01-16 |
Peter J. Balsells |
Radially loaded canted coiled spring with turn angle
|
US4907788A
(en)
|
1988-04-25 |
1990-03-13 |
Peter J. Balsells |
Dual concentric canted-coil spring apparatus
|
ATE94955T1
(en)
|
1988-04-25 |
1993-10-15 |
Peter J Balsells |
SELF-CLOSED ANROCULAR COIL SPRING WITH EXTERNAL REVERSE ANGLE.
|
US5079388A
(en)
|
1989-12-01 |
1992-01-07 |
Peter J. Balsells |
Gasket for sealing electromagnetic waves
|
US4876781A
(en)
|
1988-04-25 |
1989-10-31 |
Peter J. Balsells |
Method of making a garter-type axially resilient coiled spring
|
US4826144A
(en)
|
1988-04-25 |
1989-05-02 |
Peter J. Balsells |
Inside back angle canted coil spring
|
US4931285A
(en)
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5006346A
(en)
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US5024842A
(en)
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US5160743A
(en)
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
JP2827287B2
(en)
|
1988-07-05 |
1998-11-25 |
武田薬品工業株式会社 |
Sustained release microcapsules containing water-soluble drugs
|
JP2794022B2
(en)
|
1988-11-11 |
1998-09-03 |
三生製薬株式会社 |
Transdermal preparation containing bunazosin or its salts
|
US5057318A
(en)
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5110596A
(en)
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5728088A
(en)
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5059423A
(en)
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5034229A
(en)
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5234424A
(en)
|
1988-12-28 |
1993-08-10 |
Alza Corporation |
Osmotically driven syringe
|
US4969884A
(en)
|
1988-12-28 |
1990-11-13 |
Alza Corporation |
Osmotically driven syringe
|
US4976966A
(en)
|
1988-12-29 |
1990-12-11 |
Alza Corporation |
Delayed release osmotically driven fluid dispenser
|
IL92344A0
(en)
|
1989-01-04 |
1990-07-26 |
Gist Brocades Nv |
Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
|
US5128147A
(en)
|
1989-01-06 |
1992-07-07 |
Thermal Developments, Inc. |
Heat intensifier and localizer for radiofrequency thermotherapy
|
US5288479A
(en)
|
1989-01-17 |
1994-02-22 |
Sterling Drug, Inc. |
Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
|
US5906816A
(en)
|
1995-03-16 |
1999-05-25 |
University Of Florida |
Method for treatment of autoimmune diseases
|
US5705363A
(en)
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
US5219572A
(en)
|
1989-03-17 |
1993-06-15 |
Pitman-Moore, Inc. |
Controlled release delivery device for macromolecular proteins
|
NL8901004A
(en)
|
1989-04-21 |
1990-11-16 |
Nedap Nv |
Positioning attachment for animal implanting or injecting tool - has automatically shaped transparent positioning piece with adjustable needle insertion depth
|
NL9000948A
(en)
|
1989-04-21 |
1990-11-16 |
Nedap Nv |
Injection and implanting instrument for coding or numbering animals - has handle sliding on guide pin with insertion depth stop parallel to hollow needle and anatomically shaped locating plate
|
US5090962A
(en)
|
1989-04-28 |
1992-02-25 |
Flp Enterprises, Inc. |
Non-reusable syringe
|
EP0432232B1
(en)
|
1989-05-01 |
1994-01-05 |
Alkermes Controlled Therapeutics, Inc. |
Process for producing small particles of biologically active molecules
|
US5019400A
(en)
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
AU5741590A
(en)
|
1989-05-04 |
1990-11-29 |
Southern Research Institute |
Improved encapsulation process and products therefrom
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
US5126142A
(en)
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US5192273A
(en)
|
1989-07-24 |
1993-03-09 |
Steven F. Bierman |
Catheterization system
|
US5225205A
(en)
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
US5439688A
(en)
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
WO1991003510A1
(en)
|
1989-08-28 |
1991-03-21 |
Pharmaceutical Delivery Systems, Inc. |
Bioerodible polymers useful for the controlled release of therapeutic agents
|
US5112614A
(en)
|
1989-09-14 |
1992-05-12 |
Alza Corporation |
Implantable delivery dispenser
|
US5290558A
(en)
|
1989-09-21 |
1994-03-01 |
Osteotech, Inc. |
Flowable demineralized bone powder composition and its use in bone repair
|
SE465950B
(en)
|
1989-10-23 |
1991-11-25 |
Medinvent Sa |
Combination of an aggregate particle size, crystalline or freeze-dried drug with a pseudoplastic gel for preparation of an injectable preparation as well as a process for its preparation
|
US5707644A
(en)
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
DE69003805T2
(en)
|
1989-11-13 |
1994-05-19 |
Becton Dickinson France |
STORAGE CONTAINER FOR A COMPONENT OF A MEDICINAL SOLUTION.
|
JPH03236317A
(en)
|
1989-12-06 |
1991-10-22 |
Sansei Seiyaku Kk |
Dopamine derivative-containing percutaneous
|
US5030216A
(en)
|
1989-12-15 |
1991-07-09 |
Alza Corporation |
Osmotically driven syringe
|
US5733572A
(en)
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
USD326718S
(en)
*
|
1989-12-26 |
1992-06-02 |
Minnesota Mining And Manufacturing Co. |
Blood sensor cassette
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
US5223266A
(en)
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
US5213809A
(en)
|
1990-01-24 |
1993-05-25 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5053014A
(en)
|
1990-02-01 |
1991-10-01 |
Critikon, Inc. |
Catheter with controlled valve
|
US5126147A
(en)
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
GB2240718A
(en)
|
1990-02-09 |
1991-08-14 |
Hundon Forge Ltd |
Implanting device with needle cover
|
US5478564A
(en)
|
1990-02-22 |
1995-12-26 |
Teva Pharmaceutical Industries, Ltd. |
Preparation of microparticles for controlled release of water-soluble substances
|
US5122128A
(en)
|
1990-03-15 |
1992-06-16 |
Alza Corporation |
Orifice insert for a ruminal bolus
|
US5120306A
(en)
|
1990-03-21 |
1992-06-09 |
Gosselin Leon F |
Direct delivery of anti-inflammatories to the proximal small bowel
|
US5207752A
(en)
|
1990-03-30 |
1993-05-04 |
Alza Corporation |
Iontophoretic drug delivery system with two-stage delivery profile
|
US5213810A
(en)
|
1990-03-30 |
1993-05-25 |
American Cyanamid Company |
Stable compositions for parenteral administration and method of making same
|
US5324280A
(en)
|
1990-04-02 |
1994-06-28 |
Alza Corporation |
Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
US5290271A
(en)
|
1990-05-14 |
1994-03-01 |
Jernberg Gary R |
Surgical implant and method for controlled release of chemotherapeutic agents
|
US5374620A
(en)
|
1990-06-07 |
1994-12-20 |
Genentech, Inc. |
Growth-promoting composition and its use
|
US5234692A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234693A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234695A
(en)
|
1990-07-24 |
1993-08-10 |
Eastman Kodak Company |
Water dispersible vitamin E composition
|
US7008439B1
(en)
|
1990-09-21 |
2006-03-07 |
Datascope Investments Corp. |
Device and method for sealing puncture wounds
|
USD329278S
(en)
*
|
1990-10-01 |
1992-09-08 |
Gallup Allen I |
Infant's bathing support
|
US5300302A
(en)
|
1990-10-04 |
1994-04-05 |
Nestec S.A. |
Pharmaceutical composition in gel form in a dispensing package
|
US5529914A
(en)
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
US5151093A
(en)
|
1990-10-29 |
1992-09-29 |
Alza Corporation |
Osmotically driven syringe with programmable agent delivery
|
US5122377A
(en)
|
1990-11-19 |
1992-06-16 |
A.H. Robins, Company, Incorporated |
Oral delivery system for veterinary drugs
|
IT1243390B
(en)
|
1990-11-22 |
1994-06-10 |
Vectorpharma Int |
PHARMACEUTICAL COMPOSITIONS IN THE FORM OF PARTICLES SUITABLE FOR THE CONTROLLED RELEASE OF PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PROCEDURE FOR THEIR PREPARATION.
|
US5279544A
(en)
|
1990-12-13 |
1994-01-18 |
Sil Medics Ltd. |
Transdermal or interdermal drug delivery devices
|
US5161806A
(en)
|
1990-12-17 |
1992-11-10 |
Peter J. Balsells |
Spring-loaded, hollow, elliptical ring seal
|
GB9027422D0
(en)
|
1990-12-18 |
1991-02-06 |
Scras |
Osmotically driven infusion device
|
WO1992011843A1
(en)
|
1991-01-09 |
1992-07-23 |
Alza Corporation |
Bioerodible devices and compositions for diffusional release of agents
|
US5147295A
(en)
|
1991-01-23 |
1992-09-15 |
Ideal Instruments, Inc. |
Retractable implanter
|
US5443459A
(en)
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
NL9100160A
(en)
|
1991-01-30 |
1992-08-17 |
Texas Instruments Holland |
INJECTOR.
|
ATE125452T1
(en)
|
1991-03-06 |
1995-08-15 |
Sueddeutsche Feinmechanik |
CANNULA FOR DEPOSITING AN ELEMENT.
|
US5861166A
(en)
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
AU657973B2
(en)
|
1991-05-07 |
1995-03-30 |
Dynagen, Inc. |
A controlled, sustained release delivery system for smoking cessation
|
US5113938A
(en)
|
1991-05-07 |
1992-05-19 |
Clayton Charley H |
Whipstock
|
US5137727A
(en)
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
EP0520119A1
(en)
|
1991-06-17 |
1992-12-30 |
Spirig Ag Pharmazeutische Präparate |
New oral diclofenac composition
|
US5190765A
(en)
|
1991-06-27 |
1993-03-02 |
Alza Corporation |
Therapy delayed
|
US5252338A
(en)
|
1991-06-27 |
1993-10-12 |
Alza Corporation |
Therapy delayed
|
HU222501B1
(en)
|
1991-06-28 |
2003-07-28 |
Endorecherche Inc. |
Controlled release pharmaceutical composition containing mpa or mga and process for its preparation
|
DE4122217C2
(en)
|
1991-07-04 |
1997-02-13 |
Merz & Co Gmbh & Co |
Process for the preparation of mechanically stable, well decomposing compressed products from small active substance-containing moldings
|
US5288214A
(en)
|
1991-09-30 |
1994-02-22 |
Toshio Fukuda |
Micropump
|
YU87892A
(en)
|
1991-10-01 |
1995-12-04 |
Eli Lilly And Company Lilly Corporate Center |
INJECTIBLE LONG TERM RELEASE FORMULATIONS AND PROCEDURES FOR THEIR OBTAINING AND USE
|
EP0664118B1
(en)
|
1991-10-04 |
1999-08-25 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Sustained-release tablet
|
WO1993006819A1
(en)
|
1991-10-10 |
1993-04-15 |
Alza Corporation |
Osmotic drug delivery devices with hydrophobic wall materials
|
US5288502A
(en)
|
1991-10-16 |
1994-02-22 |
The University Of Texas System |
Preparation and uses of multi-phase microspheres
|
US5318780A
(en)
|
1991-10-30 |
1994-06-07 |
Mediventures Inc. |
Medical uses of in situ formed gels
|
US5236707A
(en)
|
1991-11-08 |
1993-08-17 |
Dallas Biotherapeutics, Inc. |
Stabilization of human interferon
|
AU3136293A
(en)
|
1991-11-15 |
1993-06-15 |
Isp Investments Inc. |
Pharmaceutical tablet with pvp having an enhanced drug dissolution rate
|
DE4137649C2
(en)
|
1991-11-15 |
1997-11-20 |
Gerhard Dingler |
Component
|
US5200195A
(en)
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5223265A
(en)
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
US5658593A
(en)
|
1992-01-16 |
1997-08-19 |
Coletica |
Injectable compositions containing collagen microcapsules
|
US5676942A
(en)
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
US5308348A
(en)
|
1992-02-18 |
1994-05-03 |
Alza Corporation |
Delivery devices with pulsatile effect
|
US5209746A
(en)
|
1992-02-18 |
1993-05-11 |
Alza Corporation |
Osmotically driven delivery devices with pulsatile effect
|
US5456679A
(en)
|
1992-02-18 |
1995-10-10 |
Alza Corporation |
Delivery devices with pulsatile effect
|
ES2152248T3
(en)
|
1992-02-28 |
2001-02-01 |
Collagen Corp |
COMPOSITIONS OF HIGH CONCENTRATION COLLAGEN.
|
US5573934A
(en)
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
US5656297A
(en)
|
1992-03-12 |
1997-08-12 |
Alkermes Controlled Therapeutics, Incorporated |
Modulated release from biocompatible polymers
|
US5221278A
(en)
|
1992-03-12 |
1993-06-22 |
Alza Corporation |
Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
|
AU3941793A
(en)
|
1992-03-30 |
1993-11-08 |
Alza Corporation |
Additives for bioerodible polymers to regulate degradation
|
MX9301823A
(en)
|
1992-03-30 |
1994-01-31 |
Alza Corp |
COMPOSITION FOR THE SUPPLY OF CONTROLLED RELEASE OF A BIOLOGICALLY ACTIVE AGENT.
|
US6197346B1
(en)
|
1992-04-24 |
2001-03-06 |
Brown Universtiy Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
FR2690622B1
(en)
|
1992-04-29 |
1995-01-20 |
Chronotec |
Programmable ambulatory infusion pump system.
|
US5314685A
(en)
|
1992-05-11 |
1994-05-24 |
Agouron Pharmaceuticals, Inc. |
Anhydrous formulations for administering lipophilic agents
|
US5250026A
(en)
|
1992-05-27 |
1993-10-05 |
Destron/Idi, Inc. |
Adjustable precision transponder injector
|
US5711968A
(en)
|
1994-07-25 |
1998-01-27 |
Alkermes Controlled Therapeutics, Inc. |
Composition and method for the controlled release of metal cation-stabilized interferon
|
JP2651320B2
(en)
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
Method for producing sustained-release microsphere preparation
|
US5413672A
(en)
|
1992-07-22 |
1995-05-09 |
Ngk Insulators, Ltd. |
Method of etching sendust and method of pattern-etching sendust and chromium films
|
US5512293A
(en)
|
1992-07-23 |
1996-04-30 |
Alza Corporation |
Oral sustained release drug delivery device
|
US5276926A
(en)
*
|
1992-08-04 |
1994-01-11 |
Raquel Lopez |
Baby bath and seat
|
US5279555A
(en)
|
1992-08-24 |
1994-01-18 |
Merck & Co., Inc. |
Device for injecting implants
|
US5609885A
(en)
|
1992-09-15 |
1997-03-11 |
Alza Corporation |
Osmotic membrane and delivery device
|
FR2696334B1
(en)
|
1992-10-01 |
1994-12-02 |
Boudjema J Pascal |
Device for transplanting small diameter hair grafts.
|
GB9223146D0
(en)
|
1992-11-05 |
1992-12-16 |
Scherer Corp R P |
Vented capsule
|
DE69224386T2
(en)
|
1992-11-06 |
1998-06-18 |
Texas Instruments Inc |
Device for subcutaneous insertion of a needle
|
DK0669128T3
(en)
|
1992-11-17 |
2000-06-19 |
Yoshitomi Pharmaceutical |
Sustained-release microsphere containing antipsychotics and method of producing same
|
USD342855S
(en)
*
|
1992-11-20 |
1994-01-04 |
Butler Ii George D |
Combined infant cushion and cover
|
US5260069A
(en)
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
SE9203594D0
(en)
|
1992-11-30 |
1992-11-30 |
Christer Nystroem |
DISPERSA SYSTEM MEDICINAL PRODUCT
|
EP1013270A3
(en)
|
1992-12-02 |
2001-03-28 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release growth hormone containing microspheres
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
RU2143889C1
(en)
|
1993-02-23 |
2000-01-10 |
Генентек, Инк. |
Method of stabilization of polypeptide, and methods of preparing polypeptide compositions
|
US5368588A
(en)
|
1993-02-26 |
1994-11-29 |
Bettinger; David S. |
Parenteral fluid medication reservoir pump
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
AU6410494A
(en)
|
1993-03-17 |
1994-10-11 |
Alza Corporation |
Device for the transdermal administration of alprazolam
|
US5514110A
(en)
|
1993-03-22 |
1996-05-07 |
Teh; Eutiquio L. |
Automatic flow control device
|
FR2703501B1
(en)
|
1993-04-01 |
1995-05-19 |
Gemplus Card Int |
Integrated circuit for memory card and method for counting units in a memory card.
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
HU225496B1
(en)
|
1993-04-07 |
2007-01-29 |
Scios Inc |
Pharmaceutical compositions of prolonged delivery, containing peptides
|
TW404844B
(en)
|
1993-04-08 |
2000-09-11 |
Oxford Biosciences Ltd |
Needleless syringe
|
NZ247516A
(en)
|
1993-04-28 |
1995-02-24 |
Bernard Charles Sherman |
Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
DE4320754A1
(en)
|
1993-06-23 |
1995-01-05 |
Hoechst Ag |
Device for applying implants
|
US5639477A
(en)
|
1993-06-23 |
1997-06-17 |
Alza Corporation |
Ruminal drug delivery device
|
US5569289A
(en)
|
1993-06-24 |
1996-10-29 |
Yoon; Inbae |
Safety penetrating instrument with penetrating member and cannula moving during penetration and triggered safety member protusion
|
DE69401945T3
(en)
|
1993-06-25 |
2004-09-02 |
Alza Corp., Palo Alto |
INTRODUCTION OF A POLY-N-VINYLAMID INTO A TRANSDERMAL SYSTEM
|
US5498255A
(en)
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
US5385887A
(en)
|
1993-09-10 |
1995-01-31 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
JP2700141B2
(en)
|
1993-09-17 |
1998-01-19 |
富士化学工業株式会社 |
Calcium hydrogen phosphate, its production method and excipient using the same
|
AU679794B2
(en)
|
1993-09-29 |
1997-07-10 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutynin
|
FI934513A
(en)
|
1993-10-13 |
1995-04-14 |
Leiras Oy |
Anordning Foer injection with implant
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
ES2172574T5
(en)
|
1993-11-19 |
2012-11-29 |
Alkermes, Inc. |
Preparation of biodegradable microparticles containing a biologically active agent
|
ES2236700T3
(en)
|
1993-11-19 |
2005-07-16 |
Janssen Pharmaceutica N.V. |
1,2-MICROENCAPSULATED BENZAZOLS.
|
US5650173A
(en)
|
1993-11-19 |
1997-07-22 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
US5348544A
(en)
|
1993-11-24 |
1994-09-20 |
Becton, Dickinson And Company |
Single-handedly actuatable safety shield for needles
|
JPH07196479A
(en)
|
1994-01-04 |
1995-08-01 |
Unitika Ltd |
Method for producing microcapsule
|
USD358644S
(en)
*
|
1994-01-18 |
1995-05-23 |
Bio Medic Data Systems, Inc. |
Transponder implanter
|
US6241734B1
(en)
|
1998-08-14 |
2001-06-05 |
Kyphon, Inc. |
Systems and methods for placing materials into bone
|
US5540665A
(en)
|
1994-01-31 |
1996-07-30 |
Alza Corporation |
Gas driven dispensing device and gas generating engine therefor
|
JP3203358B2
(en)
|
1994-02-04 |
2001-08-27 |
リポコーア・ホールディング・アクチエボラーグ |
Double layer formulation
|
US5697975A
(en)
|
1994-02-09 |
1997-12-16 |
The University Of Iowa Research Foundation |
Human cerebral cortex neural prosthetic for tinnitus
|
DE9403161U1
(en)
|
1994-02-25 |
1994-04-21 |
Süddeutsche Feinmechanik GmbH, 63607 Wächtersbach |
Cannula
|
US5458888A
(en)
|
1994-03-02 |
1995-10-17 |
Andrx Pharmaceuticals, Inc. |
Controlled release tablet formulation
|
US6007805A
(en)
|
1994-03-07 |
1999-12-28 |
Imperial College Of Science And Technology |
Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver
|
US5484403A
(en)
|
1994-04-05 |
1996-01-16 |
Avid Marketing, Inc. |
Hypodermic syringe for implanting solid objects
|
ZA953078B
(en)
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
FI942686A0
(en)
|
1994-06-07 |
1994-06-07 |
Alko Ab Oy |
Composition of the starch acetate with a variety of compounds, for the production and distribution
|
DE69431533T2
(en)
|
1994-06-13 |
2003-10-02 |
Alza Corp., Palo Alto |
DOSAGE FORM FOR ADMINISTRATION OF LIQUID MEDICINAL FORMULATION
|
NL9401150A
(en)
|
1994-07-12 |
1996-02-01 |
Nederland Ptt |
Method for presenting on a receiving side a first number of video signals originating from a transmitting side, as well as a system, as well as a transmitter, as well as a network, and also a receiver.
|
EP0804155B1
(en)
|
1994-07-13 |
2000-11-08 |
Alza Corporation |
Composition and method for enhancing transdermal electrotransport agent delivery
|
US5633011A
(en)
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
US5574008A
(en)
|
1994-08-30 |
1996-11-12 |
Eli Lilly And Company |
Biologically active fragments of glucagon-like insulinotropic peptide
|
ES2122684T3
(en)
|
1994-09-27 |
1998-12-16 |
Delab |
SAFETY INJECTION DEVICE.
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
AU708529B2
(en)
|
1994-11-10 |
1999-08-05 |
University Of Kentucky Research Foundation, The |
Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
|
US5595759A
(en)
|
1994-11-10 |
1997-01-21 |
Alza Corporation |
Process for providing therapeutic composition
|
US5613954A
(en)
|
1994-11-21 |
1997-03-25 |
Stryker Corporation |
Laparoscopic surgical Y-tube cannula
|
FR2731150B1
(en)
|
1995-03-03 |
1997-04-18 |
Oreal |
USE OF AMPHIPHILIC COMPOUNDS AS A THICKENING AGENT FOR NON-AQUEOUS MEDIA
|
US5464929A
(en)
|
1995-03-06 |
1995-11-07 |
Ethicon, Inc. |
Absorbable polyoxaesters
|
US5962023A
(en)
|
1995-03-06 |
1999-10-05 |
Ethicon, Inc. |
Hydrogels containing absorbable polyoxaamides
|
US6403655B1
(en)
|
1995-03-06 |
2002-06-11 |
Ethicon, Inc. |
Method of preventing adhesions with absorbable polyoxaesters
|
US5859150A
(en)
|
1995-03-06 |
1999-01-12 |
Ethicon, Inc. |
Prepolymers of absorbable polyoxaesters
|
US5844017A
(en)
|
1995-03-06 |
1998-12-01 |
Ethicon, Inc. |
Prepolymers of absorbable polyoxaesters containing amines and/or amido groups
|
US5597579A
(en)
|
1995-03-06 |
1997-01-28 |
Ethicon, Inc. |
Blends of absorbable polyoxaamides
|
US5648088A
(en)
|
1995-03-06 |
1997-07-15 |
Ethicon, Inc. |
Blends of absorbable polyoxaesters containing amines and/or amide groups
|
US5618552A
(en)
|
1995-03-06 |
1997-04-08 |
Ethicon, Inc. |
Absorbable polyoxaesters
|
US5700583A
(en)
|
1995-03-06 |
1997-12-23 |
Ethicon, Inc. |
Hydrogels of absorbable polyoxaesters containing amines or amido groups
|
US5595751A
(en)
|
1995-03-06 |
1997-01-21 |
Ethicon, Inc. |
Absorbable polyoxaesters containing amines and/or amido groups
|
US6100346A
(en)
|
1995-03-06 |
2000-08-08 |
Ethicon, Inc. |
Copolymers of polyoxaamides
|
US6147168A
(en)
|
1995-03-06 |
2000-11-14 |
Ethicon, Inc. |
Copolymers of absorbable polyoxaesters
|
US5607687A
(en)
|
1995-03-06 |
1997-03-04 |
Ethicon, Inc. |
Polymer blends containing absorbable polyoxaesters
|
US5698213A
(en)
|
1995-03-06 |
1997-12-16 |
Ethicon, Inc. |
Hydrogels of absorbable polyoxaesters
|
US5697914A
(en)
|
1995-03-16 |
1997-12-16 |
Becton Dickinson And Company |
Control forward/flashback forward one hand introducer needle and catheter assembly
|
IL113100A0
(en)
*
|
1995-03-23 |
1995-06-29 |
Schatz Anat |
Infant's mattress
|
US5542682A
(en)
|
1995-03-27 |
1996-08-06 |
American Variseal |
Slant coil spring and seal
|
US5736159A
(en)
|
1995-04-28 |
1998-04-07 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
|
EP0826376B1
(en)
|
1995-05-02 |
2007-01-24 |
Taisho Pharmaceutical Co. Ltd |
Composition for oral administration
|
US5939286A
(en)
|
1995-05-10 |
1999-08-17 |
University Of Florida |
Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
|
US5922253A
(en)
|
1995-05-18 |
1999-07-13 |
Alkermes Controlled Therapeutics, Inc. |
Production scale method of forming microparticles
|
US5882676A
(en)
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
US5718922A
(en)
|
1995-05-31 |
1998-02-17 |
Schepens Eye Research Institute, Inc. |
Intravitreal microsphere drug delivery and method of preparation
|
PT831826E
(en)
|
1995-06-06 |
2003-02-28 |
Hoffmann La Roche |
PHARMACEUTICAL COMPOSITION INCLUDING A PROTEINASE INHIBITOR AND A MONOGLICERIDE
|
US6572879B1
(en)
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
US5904935A
(en)
|
1995-06-07 |
1999-05-18 |
Alza Corporation |
Peptide/protein suspending formulations
|
US5725497A
(en)
|
1995-06-07 |
1998-03-10 |
American Cyanamid Company |
Injection dart system
|
UA48973C2
(en)
|
1995-06-07 |
2002-09-16 |
Орто-Макнейл Фармасьютікалз Інк. |
Transdermal patch containing 17-deacetyl norgestimate for preventing ovulation
|
US6129761A
(en)
|
1995-06-07 |
2000-10-10 |
Reprogenesis, Inc. |
Injectable hydrogel compositions
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
US5690952A
(en)
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
US6607529B1
(en)
|
1995-06-19 |
2003-08-19 |
Medtronic Vidamed, Inc. |
Electrosurgical device
|
US5782396A
(en)
|
1995-08-28 |
1998-07-21 |
United States Surgical Corporation |
Surgical stapler
|
US5906830A
(en)
|
1995-09-08 |
1999-05-25 |
Cygnus, Inc. |
Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
|
US5942253A
(en)
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
GB9521125D0
(en)
|
1995-10-16 |
1995-12-20 |
Unilever Plc |
Cosmetic composition
|
SE505146C2
(en)
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Particles for delayed release
|
US5766620A
(en)
|
1995-10-23 |
1998-06-16 |
Theratech, Inc. |
Buccal delivery of glucagon-like insulinotropic peptides
|
GB9521805D0
(en)
|
1995-10-25 |
1996-01-03 |
Cortecs Ltd |
Solubilisation methods
|
ATE235505T1
(en)
|
1995-10-30 |
2003-04-15 |
Oleoyl Estrone Developments S |
OLEAT MONOESTER OF ESTROGENS FOR THE TREATMENT OF OBESITY
|
EP0858343B1
(en)
|
1995-11-02 |
2004-03-31 |
Schering Corporation |
Continuous low-dose cytokine infusion therapy
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
US5906599A
(en)
|
1995-11-09 |
1999-05-25 |
Intermed, Inc. |
Device for delivering biological agents
|
CA2192782C
(en)
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
WO1997022379A2
(en)
|
1995-12-18 |
1997-06-26 |
Kerisma Medical Products, L.L.C. |
Fiberoptic-guided interstitial seed manual applicator and seed cartridge
|
AUPN723395A0
(en)
|
1995-12-19 |
1996-01-18 |
Macnaught Medical Pty Limited |
Lubrication methods
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
DE69625623T2
(en)
|
1996-01-31 |
2003-11-06 |
Sumitomo Bakelite Co. Ltd., Tokio/Tokyo |
Method of manufacturing semiconductor device encapsulated in epoxy resin
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
PT877599E
(en)
|
1996-02-02 |
2003-08-29 |
Alza Corp |
CONTINUOUS LEUPROLIDAL ADMINISTRATION USING AN IMPLANTABLE SYSTEM
|
US6156331A
(en)
|
1996-02-02 |
2000-12-05 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6132420A
(en)
|
1996-02-02 |
2000-10-17 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
WO1997028181A2
(en)
|
1996-02-02 |
1997-08-07 |
Rhomed Incorporated |
Post-labeling stabilization of radiolabeled proteins and peptides
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6245349B1
(en)
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
DE69740176D1
(en)
|
1996-03-01 |
2011-05-26 |
Novo Nordisk As |
Appetite inhibiting peptide, composition and use
|
JPH09241153A
(en)
|
1996-03-04 |
1997-09-16 |
Q P Corp |
Lipid emulsion for intravenous injection
|
WO1997032883A1
(en)
|
1996-03-08 |
1997-09-12 |
Zeneca Limited |
Azolobenzazepine derivatives as neurologically active agents
|
CA2248538A1
(en)
|
1996-03-14 |
1997-09-18 |
The Immune Response Corporation |
Targeted delivery of genes encoding interferon
|
US5703200A
(en)
|
1996-03-15 |
1997-12-30 |
Ethicon, Inc. |
Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer
|
DE69717263T2
(en)
|
1996-03-28 |
2003-07-24 |
Takeda Chemical Industries, Ltd. |
PREPARATION WITH DELAYED RELEASE AND THEIR PRODUCTION
|
US5660858A
(en)
|
1996-04-03 |
1997-08-26 |
Research Triangle Pharmaceuticals |
Cyclosporin emulsions
|
US6204022B1
(en)
|
1996-04-12 |
2001-03-20 |
Pepgen Corporation And University Of Florida |
Low-toxicity human interferon-alpha analogs
|
US6074673A
(en)
|
1996-04-22 |
2000-06-13 |
Guillen; Manuel |
Slow-release, self-absorbing, drug delivery system
|
US5976109A
(en)
|
1996-04-30 |
1999-11-02 |
Medtronic, Inc. |
Apparatus for drug infusion implanted within a living body
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
TW487572B
(en)
|
1996-05-20 |
2002-05-21 |
Janssen Pharmaceutica Nv |
Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
|
ES2256888T3
(en)
|
1996-06-05 |
2006-07-16 |
Roche Diagnostics Gmbh |
EXENDINE ANALOGS, PROCESS FOR PREPARATION AND DRUGS THAT CONTAIN THEM.
|
EP0928136B1
(en)
|
1996-06-05 |
2003-10-22 |
Ashmont Holdings Limited |
Injectable compositions
|
DE29610419U1
(en)
|
1996-06-14 |
1996-10-24 |
Filtertek, S.A., Plailly |
Gravity infusion device for medical infusions
|
GB9613858D0
(en)
|
1996-07-02 |
1996-09-04 |
Cortecs Ltd |
Hydrophobic preparations
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
US5916582A
(en)
|
1996-07-03 |
1999-06-29 |
Alza Corporation |
Aqueous formulations of peptides
|
AU737664B2
(en)
|
1996-07-03 |
2001-08-30 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
ES2259746T3
(en)
|
1996-07-15 |
2006-10-16 |
Alza Corporation |
NEW FORMULATIONS FOR THE TRANSDERMAL ADMINISTRATION OF FLUOXETINA.
|
AR008789A1
(en)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
PIRIDINES AND SUBSTITUTED BIPHENYLS
|
PT966297E
(en)
|
1996-08-08 |
2009-03-18 |
Amylin Pharmaceuticals Inc |
Regulation of gastrointestinal motility
|
AU3981097A
(en)
|
1996-08-21 |
1998-03-06 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release microparticles with a hydrophobic material
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
DE69731843T2
(en)
|
1996-09-27 |
2005-04-28 |
Wyeth |
MEDICAL DEVICE FOR FITTING SOLIDS
|
US5984890A
(en)
|
1996-09-27 |
1999-11-16 |
American Home Products Corporation |
Medical device for the placement of solid materials
|
AU4357397A
(en)
|
1996-09-27 |
1998-04-17 |
American Home Products Corporation |
Tissue penetration guide
|
US5919160A
(en)
|
1996-10-10 |
1999-07-06 |
Sanfilippo, Ii; Dominic Joseph |
Vascular access device and method of installing same
|
IN184589B
(en)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
ES2191834T3
(en)
|
1996-10-24 |
2003-09-16 |
Alza Corp |
AGENTS THAT FACILITATE THE PERMEATION AND DESTINATIONS FOR COMPOSITIONS, DEVICES AND PROCEDURES OF TRANSDERMAL CONTRIBUTION OF DRUGS.
|
US5817129A
(en)
|
1996-10-31 |
1998-10-06 |
Ethicon, Inc. |
Process and apparatus for coating surgical sutures
|
UA65549C2
(en)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Use of glucagon-like peptides such as glp-1, glp-1 analog, or glp-1 derivative in methods and compositions for reducing body weight
|
DE19646392A1
(en)
|
1996-11-11 |
1998-05-14 |
Lohmann Therapie Syst Lts |
Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery
|
US5928666A
(en)
|
1996-11-12 |
1999-07-27 |
Cygnus Inc. |
Crystalline form of estradiol and pharmaceutical formulations comprising same
|
PT1066081E
(en)
|
1996-11-15 |
2003-12-31 |
Alza Corp |
OSMOTIC DISTRIBUTION SYSTEM AND PROCESS FOR IMPROVING THE START AND PERFORMANCE OF OSMOTIC DISTRIBUTION SYSTEMS
|
GB9626513D0
(en)
|
1996-12-20 |
1997-02-05 |
Bioglan Ireland R & D Ltd |
A pharmaceutical composition
|
PT949905E
(en)
|
1996-12-20 |
2001-12-28 |
Alza Corp |
DELAYED EFFECT INJECTABLE GEL COMPOSITION AND PROCESS FOR THEIR PREPARATION
|
DK1629849T4
(en)
|
1997-01-07 |
2017-12-04 |
Amylin Pharmaceuticals Llc |
Pharmaceutical compositions comprising exedins and agonists thereof
|
JP2001511128A
(en)
|
1997-01-28 |
2001-08-07 |
ファルマシア・アンド・アップジョン・カンパニー |
Lyophilized product of lipid complex of water-insoluble porphyrin
|
US5945126A
(en)
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
ZA981610B
(en)
|
1997-03-24 |
1999-08-26 |
Alza Corp |
Self adjustable exit port.
|
US5874388A
(en)
|
1997-04-02 |
1999-02-23 |
Dow Corning Corporation |
Lubricant composition for disc brake caliper pin and a disc brake asembly containing the lubricant
|
US6127520A
(en)
|
1997-04-15 |
2000-10-03 |
Regents Of The University Of Michigan |
Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles
|
JP2001524958A
(en)
|
1997-04-17 |
2001-12-04 |
ジーエス ディベロップメント アクティエボラーグ |
A novel liquid crystal based bioadhesive drug delivery system
|
MY118835A
(en)
|
1997-04-18 |
2005-01-31 |
Ipsen Pharma Biotech |
Sustained release compositions and the process for their preparation
|
BR9808697A
(en)
|
1997-04-28 |
2000-07-11 |
Rhone Poulenc Rorer Sa |
Process to inhibit the growth of a tumor, defective adenovirus vector, virus vector, use of it, and pharmaceutical composition
|
US20020039594A1
(en)
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
US6113947A
(en)
|
1997-06-13 |
2000-09-05 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6663899B2
(en)
|
1997-06-13 |
2003-12-16 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
IL133379A0
(en)
|
1997-06-20 |
2001-04-30 |
Akzo Nobel Nv |
Preloaded implantation device
|
SI9700186B
(en)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Novel pharmaceutical preparation with controlled release of active healing substances
|
MY125870A
(en)
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system flow modulator apparatus and method
|
MY125849A
(en)
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
|
US7157555B1
(en)
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
DE19734385C1
(en)
|
1997-08-08 |
1999-02-18 |
Gaplast Gmbh |
Implant syringe
|
GB9718986D0
(en)
|
1997-09-09 |
1997-11-12 |
Danbiosyst Uk |
Controlled release microsphere delivery system
|
US6023802A
(en)
*
|
1997-09-10 |
2000-02-15 |
King; Susan Melton |
Infant sleeper
|
US6172046B1
(en)
|
1997-09-21 |
2001-01-09 |
Schering Corporation |
Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
ATE239447T1
(en)
|
1997-09-29 |
2003-05-15 |
Inhale Therapeutic Syst |
STABILIZED PREPARATIONS USABLE IN NEBULIZERS
|
JPH11100353A
(en)
|
1997-09-29 |
1999-04-13 |
Esupo Kk |
Refined and deodorized liquid ester wax and its composition
|
US6133429A
(en)
|
1997-10-03 |
2000-10-17 |
Becton Dickinson And Company |
Chromophores useful for the preparation of novel tandem conjugates
|
USD399821S
(en)
*
|
1997-11-07 |
1998-10-20 |
Motorola, Inc. |
Front section of a battery charger
|
JP2001523688A
(en)
|
1997-11-14 |
2001-11-27 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
New exendin agonist compounds
|
CA2311681A1
(en)
|
1997-12-08 |
1999-06-17 |
Genentech, Inc. |
Human interferon-epsilon: a type i interferon
|
US6368612B1
(en)
|
1997-12-12 |
2002-04-09 |
Biohybrid Technologies Llc |
Devices for cloaking transplanted cells
|
US20030059471A1
(en)
|
1997-12-15 |
2003-03-27 |
Compton Bruce Jon |
Oral delivery formulation
|
JP4215188B2
(en)
|
1997-12-22 |
2009-01-28 |
インターシア セラピューティクス,インコーポレイティド |
Rate-regulating membranes for devices that regulate drug delivery
|
EP1300174B1
(en)
|
1997-12-29 |
2005-02-16 |
Alza Corporation |
Implant insertion kit
|
AU1828599A
(en)
|
1997-12-29 |
1999-07-19 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
ATE289213T1
(en)
|
1997-12-29 |
2005-03-15 |
Alza Corp |
KIT FOR IMPLANTING AN IMPLANT
|
EP1041974B1
(en)
|
1997-12-30 |
2006-10-11 |
Alza Corporation |
Beneficial agent delivery system with membrane plug
|
US20040024068A1
(en)
|
1998-01-23 |
2004-02-05 |
Trustees Of Tufts College |
Antimicrobial compounds
|
IT1298575B1
(en)
|
1998-02-06 |
2000-01-12 |
Vectorpharma Int |
PHARMACEUTICAL COMPOSITIONS IN THE FORM OF NANOPARTICLES INCLUDING LIPID SUBSTANCES AND ANTIPHILIC SUBSTANCES AND RELATED PROCESS OF
|
US6017545A
(en)
|
1998-02-10 |
2000-01-25 |
Modi; Pankaj |
Mixed micellar delivery system and method of preparation
|
ATE366115T1
(en)
|
1998-02-13 |
2007-07-15 |
Amylin Pharmaceuticals Inc |
INOTROPIC AND DIURETIC EFFECTS OF EXENDIN AND GLP-1
|
US6703359B1
(en)
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
KR100246044B1
(en)
|
1998-02-20 |
2000-03-15 |
성재갑 |
Administration device
|
USD408917S
(en)
*
|
1998-02-26 |
1999-04-27 |
Minnesota Mining And Manufacturing Company |
Membrane support structure of a flow through cell for blood gas measurement
|
US6224577B1
(en)
|
1998-03-02 |
2001-05-01 |
Medrad, Inc. |
Syringes and plungers for use therein
|
US6056718A
(en)
|
1998-03-04 |
2000-05-02 |
Minimed Inc. |
Medication infusion set
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US6183461B1
(en)
|
1998-03-11 |
2001-02-06 |
Situs Corporation |
Method for delivering a medication
|
US20020136848A1
(en)
|
1998-03-12 |
2002-09-26 |
Fumio Yoshii |
Lactone-containing resin composition, molded object thereof, and film
|
US6029361A
(en)
|
1998-03-25 |
2000-02-29 |
Ultratech Stepper, Inc. |
Air-guage nozzle probe structure for microlithographic image focusing
|
US6395282B1
(en)
|
1998-04-16 |
2002-05-28 |
University Of Rochester |
Immunogenic conjugates of Gram-negative bacterial autoinducer molecules
|
US6074660A
(en)
|
1998-04-20 |
2000-06-13 |
Ethicon, Inc. |
Absorbable polyoxaesters containing amines and/ or amido groups
|
TW586944B
(en)
|
1998-05-29 |
2004-05-11 |
Sumitomo Pharma |
Controlled release agent having a multi-layer structure
|
US8626302B2
(en)
|
1998-06-03 |
2014-01-07 |
Spr Therapeutics, Llc |
Systems and methods to place one or more leads in muscle for providing electrical stimulation to treat pain
|
WO1999064061A1
(en)
|
1998-06-12 |
1999-12-16 |
Bionebraska, Inc. |
GLUCAGON-LIKE PEPTIDE-1 IMPROVES β-CELL RESPONSE TO GLUCOSE IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE
|
JP3405201B2
(en)
|
1998-06-17 |
2003-05-12 |
住友電装株式会社 |
Manufacturing method of equipment connector
|
ES2325141T3
(en)
|
1998-07-17 |
2009-08-26 |
Pacira Pharmaceuticals, Inc. |
BIODEGRADABLE COMPOSITIONS FOR THE CONTROLLED RELEASE OF ENCAPSULATED SUBSTANCES.
|
US7390637B2
(en)
|
1998-07-21 |
2008-06-24 |
Human Genome Sciences, Inc. |
Keratinocyte derived interferon
|
US6472512B1
(en)
|
1998-07-21 |
2002-10-29 |
Human Genome Sciences, Inc. |
Keratinocyte derived interferon
|
US6270700B1
(en)
|
1998-07-23 |
2001-08-07 |
Societe De Conseils De Recherches Et D'applications Scientifiques, Sas |
Encapsulation of water soluble peptides
|
USD415073S
(en)
*
|
1998-08-17 |
1999-10-12 |
ScooterBug, Inc. |
Stroller
|
US6720407B1
(en)
|
1998-08-28 |
2004-04-13 |
Eli Lilly And Company |
Method for administering insulinotropic peptides
|
US6551613B1
(en)
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
US6174547B1
(en)
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
DE69928815T2
(en)
|
1998-09-09 |
2006-06-29 |
Alza Corp., Mountain View |
DOSAGE FORM WITH LIQUID FORMULATION
|
US5951521A
(en)
|
1998-09-25 |
1999-09-14 |
Minimed Inc. |
Subcutaneous implantable sensor set having the capability to remove deliver fluids to an insertion site
|
US6248112B1
(en)
|
1998-09-30 |
2001-06-19 |
C. R. Bard, Inc. |
Implant delivery system
|
US6645192B2
(en)
|
1998-09-30 |
2003-11-11 |
Ivy Animal Health, Inc. |
Pellet implant system for immediate and delayed release of antiparasitic drug
|
US6284725B1
(en)
|
1998-10-08 |
2001-09-04 |
Bionebraska, Inc. |
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
|
US6053927A
(en)
*
|
1998-10-15 |
2000-04-25 |
Rsh-Gs Trust |
Apparatus and method for implant removal
|
US6544239B2
(en)
|
1998-10-16 |
2003-04-08 |
Bio-Plexus Delaware, Inc. |
Releasable locking needle assembly with optional release accessory therefor
|
JP2002528486A
(en)
|
1998-11-02 |
2002-09-03 |
アルザ・コーポレーション |
Delivery control of active substance
|
AU1623300A
(en)
|
1998-11-13 |
2000-06-05 |
Sensor Technologies, Inc. |
Monodisperse preparations useful with implanted devices
|
US20030060425A1
(en)
|
1998-11-24 |
2003-03-27 |
Ahlem Clarence N. |
Immune modulation method using steroid compounds
|
CZ295890B6
(en)
|
1998-12-07 |
2005-11-16 |
Societe De Conseils De Recherches Et D'application |
GLP-1 analogues having aminoisobutyric acid in position 8 and D-arginine in position 36, their use and pharmaceutical compositions in which the analogues are comprised
|
CA2354472C
(en)
|
1998-12-17 |
2009-02-24 |
Alza Corporation |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
ATE251448T1
(en)
|
1998-12-23 |
2003-10-15 |
Amgen Inc |
POLYOL/OIL SUSPENSIONS FOR DELAYED RELEASE OF PROTEINS
|
WO2000039280A2
(en)
|
1998-12-31 |
2000-07-06 |
Viragen, Inc. |
Leukocyte-derived interferon preparations
|
US6433144B1
(en)
|
1999-01-12 |
2002-08-13 |
Viragen, Inc. |
Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods
|
DE69906132T2
(en)
|
1998-12-31 |
2003-12-18 |
Alza Corp., Mountain View |
OSMOTIC ADMINISTRATION SYSTEM WITH SPILLAGE PISTONS
|
WO2000040273A2
(en)
|
1999-01-08 |
2000-07-13 |
Vical Incorporated |
Treatment of viral diseases using an interferon omega expressing polynucleotide
|
US6703225B1
(en)
|
1999-01-12 |
2004-03-09 |
Sumitomo Pharmaceuticals Company, Limited |
Interferon-α
|
DE60021166T3
(en)
|
1999-01-14 |
2019-08-22 |
Amylin Pharmaceuticals, Llc |
NEW EXENDIN AGONIST FORMULATIONS AND THEIR ADMINISTRATION
|
ES2343072T3
(en)
|
1999-01-14 |
2010-07-22 |
Amylin Pharmaceuticals, Inc. |
EXENDINA FOR THE SUPPRESSION OF GLUCAGON.
|
US7399489B2
(en)
|
1999-01-14 |
2008-07-15 |
Amylin Pharmaceuticals, Inc. |
Exendin analog formulations
|
US7651505B2
(en)
|
2002-06-17 |
2010-01-26 |
Senorx, Inc. |
Plugged tip delivery for marker placement
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
PT1666026E
(en)
|
1999-02-08 |
2012-03-15 |
Intarcia Therapeutics Inc |
Non-aqueous single phase biocompatible viscous vehicles and methods for preparing the same
|
US6451974B1
(en)
|
1999-03-17 |
2002-09-17 |
Novo Nordisk A/S |
Method of acylating peptides and novel acylating agents
|
US6835194B2
(en)
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
US6541021B1
(en)
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
JP2002540850A
(en)
|
1999-04-05 |
2002-12-03 |
ファーマシューティカル ディスカバリー コーポレイション |
Method for fine powder formation
|
GB9907658D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Chemical compounds
|
CN1355708A
(en)
|
1999-04-19 |
2002-06-26 |
先灵公司 |
HCV combination therapy containing ribavirin in association with antioxidants
|
US6924264B1
(en)
|
1999-04-30 |
2005-08-02 |
Amylin Pharmaceuticals, Inc. |
Modified exendins and exendin agonists
|
US6291013B1
(en)
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
WO2000067728A2
(en)
|
1999-05-07 |
2000-11-16 |
Pharmasol Gmbh |
Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
|
USD430671S
(en)
|
1999-05-10 |
2000-09-05 |
Shute Wallace B |
Obstetrical forceps
|
US6428517B1
(en)
|
1999-05-10 |
2002-08-06 |
Milestone Scientific, Inc. |
Hand-piece for injection device with a retractable and rotating needle
|
US6849714B1
(en)
|
1999-05-17 |
2005-02-01 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
ES2209885T3
(en)
|
1999-05-17 |
2004-07-01 |
Conjuchem, Inc. |
LONG-TERM INSULINOTROPIC PEPTIDES.
|
US6514500B1
(en)
|
1999-10-15 |
2003-02-04 |
Conjuchem, Inc. |
Long lasting synthetic glucagon like peptide {GLP-!}
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
US6146139A
(en)
|
1999-06-01 |
2000-11-14 |
Harrison, Iii; Louis V. |
Forceps apparatus
|
EP1187639A1
(en)
|
1999-06-04 |
2002-03-20 |
Delrx Pharmaceutical Corporation |
Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
|
CN100370967C
(en)
|
1999-06-04 |
2008-02-27 |
阿尔萨公司 |
Implantable gel compositions and method of mfg.
|
US20030059376A1
(en)
|
1999-06-04 |
2003-03-27 |
Libbey Miles A. |
Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
|
US20010040326A1
(en)
|
1999-06-14 |
2001-11-15 |
Lord Corporation |
Resilient member with deformed element and method of forming same
|
US6833256B1
(en)
|
1999-06-22 |
2004-12-21 |
University Of Maryland |
Interferon tau mutants and methods for making them
|
US6528486B1
(en)
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
US7766924B1
(en)
|
1999-07-28 |
2010-08-03 |
Cardica, Inc. |
System for performing anastomosis
|
USD445975S1
(en)
*
|
1999-08-27 |
2001-07-31 |
Black & Decker, Inc. |
Base unit for a hand held vacuum cleaner
|
SE9903236D0
(en)
|
1999-09-10 |
1999-09-10 |
Astra Ab |
Method of obtaining microparticles
|
AU8026600A
(en)
|
1999-10-15 |
2001-04-30 |
Deschutes Medical Products, Inc. |
Brachytherapy instrument and methods
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US6284283B1
(en)
|
1999-10-21 |
2001-09-04 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents and uses thereof
|
US6436091B1
(en)
|
1999-11-16 |
2002-08-20 |
Microsolutions, Inc. |
Methods and implantable devices and systems for long term delivery of a pharmaceutical agent
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
WO2001043528A2
(en)
|
1999-12-17 |
2001-06-21 |
Durect Corporation |
Devices and methods in intracerebrospinal delivery of morphine-6-glucuronide
|
DE60023361T2
(en)
|
1999-12-21 |
2006-04-27 |
Alza Corp., Mountain View |
VALVE FOR OSMOTIC DEVICES
|
US6498193B2
(en)
|
1999-12-22 |
2002-12-24 |
Trustees Of Dartmouth College |
Treatment for complications of type 2 diabetes
|
US6283949B1
(en)
|
1999-12-27 |
2001-09-04 |
Advanced Cardiovascular Systems, Inc. |
Refillable implantable drug delivery pump
|
US6572890B2
(en)
|
2000-01-13 |
2003-06-03 |
Osmotica Corp. |
Osmotic device containing venlafaxine and an anti-psychotic agent
|
US6472060B1
(en)
|
2000-01-19 |
2002-10-29 |
Seco Tools Ab |
Coated body with nanocrystalline CVD coating for enhanced edge toughness and reduced friction
|
US6844321B2
(en)
|
2000-01-31 |
2005-01-18 |
Novo Nordisk A/S |
Crystallization of a GLP-1 analogue
|
US6465425B1
(en)
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
US6471688B1
(en)
|
2000-02-15 |
2002-10-29 |
Microsolutions, Inc. |
Osmotic pump drug delivery systems and methods
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
FI20000572A
(en)
|
2000-03-13 |
2001-09-14 |
Leiras Oy |
Device intended for application of implants
|
EP1267912A2
(en)
|
2000-03-14 |
2003-01-02 |
Burkhard Göke |
Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
|
US20030211974A1
(en)
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
DE10014518A1
(en)
|
2000-03-23 |
2001-10-04 |
Aventis Pharma Gmbh |
Device for applying implants
|
TWI250874B
(en)
|
2000-03-24 |
2006-03-11 |
Nat Health Research Institutes |
Pharmaceutical compositions for preventing or treating disorders associated with bacterial or viral infection
|
EP1274459B1
(en)
|
2000-04-19 |
2005-11-16 |
Genentech, Inc. |
Sustained release formulations comprising growth hormone
|
EP1278551A2
(en)
|
2000-04-21 |
2003-01-29 |
Vical Incorporated |
Compositions and methods for (in vivo) delivery of polynucleotide-based therapeutics
|
US6589157B2
(en)
|
2000-05-18 |
2003-07-08 |
Integrated Implant Systems, L.L.C. |
Drive mechanism for medical instrument
|
AU2001263230B2
(en)
|
2000-05-19 |
2005-03-10 |
Amylin Pharmaceuticals, Llc |
Treatment of acute coronary syndrome with glp-1
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
DK1695983T3
(en)
|
2000-06-16 |
2009-05-18 |
Lilly Co Eli |
Glucagon-like peptide-1 analogues
|
US6479065B2
(en)
|
2000-08-10 |
2002-11-12 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
US6547250B1
(en)
|
2000-08-21 |
2003-04-15 |
Westport Research Inc. |
Seal assembly with two sealing mechanisms for providing static and dynamic sealing
|
US8454552B2
(en)
|
2000-08-24 |
2013-06-04 |
Cardiac Science Corporation |
Method for constructing an instrument with a covered bore for subcutaneous implantation
|
US8251946B2
(en)
|
2000-08-24 |
2012-08-28 |
Cardiac Science, Inc. |
Method for constructing an instrument with a two-part plunger for subcutaneous implantation
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
CA2423431A1
(en)
|
2000-10-06 |
2002-04-11 |
Durect Corporation |
Devices and methods for management of inflammation
|
KR20040007413A
(en)
|
2000-11-03 |
2004-01-24 |
바이오메디신즈 인코포레이티드 |
Method for short-term and long-term drug dosimetry
|
EP1335704A2
(en)
|
2000-11-16 |
2003-08-20 |
Durect Corporation |
Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
|
US6626863B1
(en)
|
2000-11-22 |
2003-09-30 |
Nusaf, L.L.C. |
Safety syringe
|
US20050070883A1
(en)
|
2000-11-29 |
2005-03-31 |
Brown James E |
Devices and methods for controlled delivery from a drug delivery device
|
US20020165286A1
(en)
|
2000-12-08 |
2002-11-07 |
Hanne Hedeman |
Dermal anti-inflammatory composition
|
WO2002047716A2
(en)
|
2000-12-13 |
2002-06-20 |
Eli Lilly And Company |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
AU2002228608A1
(en)
|
2000-12-13 |
2002-06-24 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
RU2275207C2
(en)
|
2000-12-14 |
2006-04-27 |
Амилин Фармасьютикалз, Инк. |
Method for decreasing of nutrient availability and method for appetite suppression
|
US7052483B2
(en)
*
|
2000-12-19 |
2006-05-30 |
Animas Corporation |
Transcutaneous inserter for low-profile infusion sets
|
AU2002232824A1
(en)
|
2000-12-21 |
2002-07-01 |
Inhale Therapeutic Systems, Inc. |
Induced phase transition method for the production of microparticles containing hydrophobic active agents
|
USD472896S1
(en)
*
|
2000-12-23 |
2003-04-08 |
Andreas Peiker |
Telephone support
|
USD456776S1
(en)
*
|
2001-01-23 |
2002-05-07 |
Datex - Ohmeda, Inc. |
Snap sensor connector
|
IN188924B
(en)
|
2001-03-01 |
2002-11-23 |
Bharat Serums & Vaccines Ltd |
|
EP1379197A4
(en)
|
2001-03-23 |
2009-06-03 |
Durect Corp |
Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
JP2005506956A
(en)
|
2001-06-01 |
2005-03-10 |
イーライ・リリー・アンド・カンパニー |
Long-acting GLP-1 formulation
|
US6514517B2
(en)
|
2001-06-20 |
2003-02-04 |
Ethicon, Inc. |
Antimicrobial coatings for medical devices
|
US7318931B2
(en)
|
2001-06-21 |
2008-01-15 |
Genentech, Inc. |
Sustained release formulation
|
ATE478656T1
(en)
|
2001-06-22 |
2010-09-15 |
Univ Johns Hopkins Med |
BIODEGRADABLE POLYMER COMPOSITIONS, COMPOSITIONS AND RELATED USES
|
US7163688B2
(en)
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
EP1401503B1
(en)
|
2001-06-22 |
2007-05-09 |
Pfizer Products Inc. |
Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug and a solubility-enhancing polymer
|
CA2451187C
(en)
|
2001-06-22 |
2012-08-14 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
US20030138403A1
(en)
|
2001-06-29 |
2003-07-24 |
Maxygen Aps |
Interferon formulations
|
IL159784A0
(en)
|
2001-07-20 |
2004-06-20 |
Intermune Inc |
Methods of treating liver fibrosis
|
US7576050B2
(en)
|
2001-07-31 |
2009-08-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
GLP-1 exendin-4 peptide analogs and uses thereof
|
MXPA04001525A
(en)
|
2001-08-23 |
2004-05-31 |
Lilly Co Eli |
Glucagon-like peptide-1 analogs.
|
GB0121709D0
(en)
|
2001-09-07 |
2001-10-31 |
Imp College Innovations Ltd |
Food inhibition agent
|
US20030064095A1
(en)
|
2001-09-14 |
2003-04-03 |
Imedd, Inc. |
Microfabricated nanopore device for sustained release of therapeutic agent
|
EP1435919B1
(en)
|
2001-09-17 |
2009-09-23 |
Durect Corporation |
Device and method for accurate delivery of an active agent
|
AU2002332054B2
(en)
|
2001-09-24 |
2007-11-08 |
Imperial Innovations Limited |
Modification of feeding behavior
|
US7041646B2
(en)
|
2001-10-05 |
2006-05-09 |
Bayer Pharmaceuticals Corporation |
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
|
KR20050030886A
(en)
|
2001-10-05 |
2005-03-31 |
인터뮨, 인크. |
Method of treating hepatitis virus infection with a multiphasic interferon delivery profilie
|
US20030078618A1
(en)
|
2001-10-19 |
2003-04-24 |
Fey Kate E. |
System and method for removing implanted devices
|
WO2003034960A1
(en)
|
2001-10-24 |
2003-05-01 |
Med-El Elektromedizinische Geräte Ges.m.b.H. |
Implantable fluid delivery apparatuses and implantable electrode
|
US20040142902A1
(en)
|
2001-11-08 |
2004-07-22 |
Struijker- Boudier Harry A.J. |
Implant dosage form and use thereof for the delivery of a cholosterol lowering agent
|
CN100438870C
(en)
|
2001-11-09 |
2008-12-03 |
精达制药公司 |
Method for treating diseases with omega interferon
|
WO2003041685A1
(en)
|
2001-11-14 |
2003-05-22 |
Alza Corporation |
Injectable depot composition
|
ATE507816T1
(en)
|
2001-11-14 |
2011-05-15 |
Durect Corp |
INJECTABLE DEPOSIT COMPOSITIONS AND USE THEREOF
|
NZ533436A
(en)
|
2001-11-14 |
2007-10-26 |
Alza Corp |
Catheter injectable depot compositons and uses thereof
|
DE10159217A1
(en)
|
2001-11-27 |
2003-06-05 |
Schering Ag |
17alpha-alkyl-17ß-oxy-estratrienes and intermediates for their preparation, use of 17alpha-alkyl-17ß-oxy-estratriene for the preparation of medicaments and pharmaceutical preparations
|
US20030108608A1
(en)
|
2001-12-12 |
2003-06-12 |
Erik Laridon |
Thermoplastic articles comprising silver-containing antimicrobials and high amounts of carboxylic acid salts for increased surface-available silver
|
US20030135153A1
(en)
|
2001-12-17 |
2003-07-17 |
Charles Hagemeier |
Drug implant injection device
|
EP1323450B1
(en)
|
2001-12-18 |
2004-09-22 |
Rexam Pharma GmbH |
Syringe device
|
US20030232078A1
(en)
|
2001-12-19 |
2003-12-18 |
Dong Liang C. |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
ES2500918T3
(en)
|
2001-12-21 |
2014-10-01 |
Human Genome Sciences, Inc. |
Albumin and interferon beta fusion proteins
|
US8058233B2
(en)
|
2002-01-10 |
2011-11-15 |
Oregon Health And Science University |
Modification of feeding behavior using PYY and GLP-1
|
US7105489B2
(en)
|
2002-01-22 |
2006-09-12 |
Amylin Pharmaceuticals, Inc. |
Methods and compositions for treating polycystic ovary syndrome
|
WO2003066585A2
(en)
|
2002-02-08 |
2003-08-14 |
Alkermes Controlled Therapeutics, Inc. |
Polymer-based compositions for sustained release
|
CA2476589C
(en)
|
2002-02-27 |
2014-02-25 |
Pharmain, Ltd. |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
US7635463B2
(en)
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
GB2386066A
(en)
|
2002-02-28 |
2003-09-10 |
Norbrook Lab Ltd |
Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
|
GB0204722D0
(en)
|
2002-02-28 |
2002-04-17 |
Norferm Da |
Method
|
US7258873B2
(en)
|
2002-04-11 |
2007-08-21 |
Medimmune Vaccines, Inc. |
Preservation of bioactive materials by spray drying
|
US6960192B1
(en)
|
2002-04-23 |
2005-11-01 |
Insulet Corporation |
Transcutaneous fluid delivery system
|
US7914488B2
(en)
|
2002-05-22 |
2011-03-29 |
C. Dickerson Co. |
Safety needle introducer and universal needle protector for vascular access devices
|
PT2561860T
(en)
|
2002-05-31 |
2018-05-08 |
Titan Pharmaceuticals Inc |
Implantable polymeric device for sustained release of buprenorphine
|
CA2489325C
(en)
|
2002-06-17 |
2010-08-10 |
Alza Corporation |
Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
KR101046903B1
(en)
|
2002-06-26 |
2011-07-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
Minimal bouncing volumetric efficiency piston for osmotic drug delivery systems
|
US7177526B2
(en)
|
2002-06-28 |
2007-02-13 |
Intel Corporation |
System and method for improving audio during post-production of video recordings
|
CN1684663A
(en)
|
2002-07-31 |
2005-10-19 |
阿尔萨公司 |
Injectable multimodal polymer depot compositions and uses thereof
|
AU2002359397B2
(en)
|
2002-07-31 |
2009-01-29 |
Durect Corporation |
Injectable depot compositions and uses thereof
|
US20080260838A1
(en)
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
US20060084922A1
(en)
|
2002-09-04 |
2006-04-20 |
Ruark Botha |
Device for securing a blood vessel cannula to a body
|
TWI282271B
(en)
|
2002-09-18 |
2007-06-11 |
Allergan Inc |
Apparatus for delivery of ocular implants
|
US6899717B2
(en)
|
2002-09-18 |
2005-05-31 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
US20040121009A1
(en)
|
2002-10-17 |
2004-06-24 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
US7462365B2
(en)
|
2002-10-17 |
2008-12-09 |
Costantino Henry R |
Microencapsulation and sustained release of biologically active polypeptides
|
ES2320754T3
(en)
|
2002-10-22 |
2009-05-28 |
Waratah Pharmaceuticals, Inc. |
TREATMENT OF DIABETES.
|
JP2006508127A
(en)
|
2002-11-06 |
2006-03-09 |
アルザ・コーポレーション |
Controlled release depot formulation
|
US20060121047A1
(en)
|
2002-11-20 |
2006-06-08 |
Tracey Kevin J |
Use of hmgb polypetides for increasing immune responses
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
US7014636B2
(en)
|
2002-11-21 |
2006-03-21 |
Alza Corporation |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
|
US7790681B2
(en)
|
2002-12-17 |
2010-09-07 |
Amylin Pharmaceuticals, Inc. |
Treatment of cardiac arrhythmias with GLP-1 receptor ligands
|
JP2006512370A
(en)
|
2002-12-19 |
2006-04-13 |
アルザ・コーポレーション |
A stable non-aqueous single phase gel and its formulation for delivery from an implantable device
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
GB0300571D0
(en)
|
2003-01-10 |
2003-02-12 |
Imp College Innovations Ltd |
Modification of feeding behaviour
|
JP2004238392A
(en)
|
2003-01-14 |
2004-08-26 |
Nipro Corp |
Stabilized proteinic preparation
|
US7507114B2
(en)
|
2003-02-18 |
2009-03-24 |
Medconx, Inc. |
Male medical device electrical connector with engineered friction fit
|
TW200505500A
(en)
|
2003-03-31 |
2005-02-16 |
Alza Corp |
Non-aqueous single phase vehicles and formulations utilizing such vehicles
|
MXPA05010604A
(en)
|
2003-03-31 |
2005-11-23 |
Alza Corp |
Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems.
|
JP2006521897A
(en)
|
2003-03-31 |
2006-09-28 |
アルザ・コーポレーション |
Osmotic pump with means for dissipating internal pressure
|
US7214206B2
(en)
*
|
2003-04-03 |
2007-05-08 |
Valera Pharmaceuticals, Inc. |
Implanting device and method of using same
|
WO2004103342A2
(en)
|
2003-05-16 |
2004-12-02 |
Alkermes Controlled Therapeutics, Inc. |
Injectable sustained release compositions
|
JP2007504920A
(en)
|
2003-05-16 |
2007-03-08 |
ブルー メンブレーンス ゲーエムベーハー |
Biocompatible coated medical implant
|
WO2005000222A2
(en)
|
2003-05-30 |
2005-01-06 |
Amylin Pharmaceuticals, Inc. |
Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
US20050079202A1
(en)
|
2003-05-30 |
2005-04-14 |
Guohua Chen |
Implantable elastomeric depot compositions and uses thereof
|
CN102940879B
(en)
|
2003-06-03 |
2017-06-06 |
诺沃挪第克公司 |
Stabilized pharmaceutical peptide compositions
|
US8491571B2
(en)
|
2003-06-12 |
2013-07-23 |
Cordis Corporation |
Orifice device having multiple channels with varying flow rates for drug delivery
|
US7454765B2
(en)
|
2003-07-09 |
2008-11-18 |
Samsung Electronics Co., Ltd. |
Optical disc drive
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
CN1859900A
(en)
|
2003-09-30 |
2006-11-08 |
阿尔萨公司 |
Osmotically driven active agent delivery device providing an ascending release profile
|
US9005244B2
(en)
|
2003-09-30 |
2015-04-14 |
Ethicon, Inc. |
Tissue approximation device
|
RU2006118808A
(en)
|
2003-10-31 |
2007-12-10 |
Алза Корпорейшн (Us) |
OSMOTIC PUMP WITH SELF-RETAINING PERFORMANCE EXECUTED WITH THE OPPORTUNITY OF QUICK START OF THE MEMBRANE STOP
|
RU2006119632A
(en)
|
2003-11-06 |
2007-12-20 |
Алза Корпорейшн (Us) |
MODULAR ABSORBING SPEED LIMITER FOR USE WITH AN IMPLANTED OSMOSIS PUMP
|
US20050106214A1
(en)
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US20050118206A1
(en)
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
US20050281879A1
(en)
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US7780973B2
(en)
|
2003-12-15 |
2010-08-24 |
Ethicon Endo-Surgery, Inc. |
Method and device for minimally invasive implantation of biomaterial
|
US8123757B2
(en)
|
2003-12-31 |
2012-02-28 |
Depuy Spine, Inc. |
Inserter instrument and implant clip
|
US20050216087A1
(en)
|
2004-01-05 |
2005-09-29 |
St. Francis Medical Technologies, Inc. |
Disk repair structures for positioning disk repair material
|
US20050175701A1
(en)
|
2004-02-10 |
2005-08-11 |
Alza Corporation |
Capillary moderator for osmotic delivery system
|
US8076288B2
(en)
|
2004-02-11 |
2011-12-13 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides having glucose lowering activity
|
BRPI0507594A
(en)
|
2004-02-11 |
2007-07-03 |
Amylin Pharmaceuticals Inc |
hybrid polypeptides with selectable properties
|
TWI434676B
(en)
|
2004-03-19 |
2014-04-21 |
Merck Sharp & Dohme |
X-ray visible drug delivery device
|
WO2005089723A1
(en)
|
2004-03-24 |
2005-09-29 |
N.V. Organon |
Drug delivery system based on polyethylene vinylacetate copolymers
|
US7456254B2
(en)
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
CN1968700A
(en)
|
2004-04-15 |
2007-05-23 |
阿尔克姆斯有限公司 |
Polymer-based sustained release device
|
WO2005112977A2
(en)
|
2004-04-23 |
2005-12-01 |
Pharmain, Ltd. |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
US20050266087A1
(en)
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
US20090042781A1
(en)
|
2004-06-28 |
2009-02-12 |
Novo Nordisk A/S |
Methods for Treating Diabetes
|
US7772182B2
(en)
|
2004-08-05 |
2010-08-10 |
Alza Corporation |
Stable suspension formulations of erythropoietin receptor agonists
|
DE112005001978B4
(en)
|
2004-08-18 |
2014-01-16 |
Waters Technologies Corp. (N.D.Ges.D. Staates Delaware) |
Defined leakage path for high pressure seal
|
US8268791B2
(en)
|
2004-08-25 |
2012-09-18 |
Aegis Therapeutics, Llc. |
Alkylglycoside compositions for drug administration
|
US20060094693A1
(en)
|
2004-09-21 |
2006-05-04 |
Point Therapeutics, Inc. |
Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
MX366832B
(en)
|
2004-10-01 |
2019-07-24 |
Ramscor Inc |
Conveniently implantable sustained release drug compositions.
|
US7442682B2
(en)
|
2004-10-19 |
2008-10-28 |
Nitto Denko Corporation |
Transepithelial delivery of peptides with incretin hormone activities
|
US7604647B2
(en)
|
2004-10-22 |
2009-10-20 |
Medical Instrument Development Laboratories, Inc. |
Ophthalmic cannula insertion tool and method
|
ATE427759T1
(en)
|
2004-11-01 |
2009-04-15 |
Amylin Pharmaceuticals Inc |
TREATMENT OF OBESITY AND RELATED DISEASES
|
US8394765B2
(en)
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
US7575579B2
(en)
|
2004-11-18 |
2009-08-18 |
Union Surgical, Llc |
Drill guide tissue protector
|
US20060141040A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
US20060142234A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
EP1841448A2
(en)
|
2004-12-30 |
2007-10-10 |
Diakine Therapeutics, Inc. |
Pharmaceutical compositions and methods for restoring beta-cell mass and function
|
USD587374S1
(en)
*
|
2005-01-14 |
2009-02-24 |
Edwards Lifesciences Corporation |
Sensor case
|
EP3417905B2
(en)
|
2005-01-24 |
2023-09-13 |
Merck Sharp & Dohme B.V. |
Applicator for inserting an implant
|
EP1841492B1
(en)
|
2005-01-24 |
2016-08-10 |
Merck Sharp & Dohme B.V. |
Applicator for inserting an implant
|
WO2006081279A2
(en)
|
2005-01-25 |
2006-08-03 |
Microchips, Inc. |
Control of drug release by transient modification of local microenvironments
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
EP2361630A1
(en)
|
2005-02-03 |
2011-08-31 |
Intarcia Therapeutics, Inc |
Implantable drug delivery device comprising particles and an osmotic pump
|
US20060216242A1
(en)
|
2005-02-03 |
2006-09-28 |
Rohloff Catherine M |
Suspending vehicles and pharmaceutical suspensions for drug dosage forms
|
US20070032420A1
(en)
|
2005-02-09 |
2007-02-08 |
Entelos, Inc. |
Treating diabetes with glucagon-like peptide-1 secretagogues
|
US8263545B2
(en)
|
2005-02-11 |
2012-09-11 |
Amylin Pharmaceuticals, Inc. |
GIP analog and hybrid polypeptides with selectable properties
|
BRPI0606992A2
(en)
|
2005-02-11 |
2009-07-28 |
Amylin Pharmaceuticals Inc |
gip analog and polypeptides with selectable properties
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
US7959938B2
(en)
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
KR101383493B1
(en)
|
2005-03-31 |
2014-04-11 |
아스트라제네카 파마수티컬스 엘피 |
Amylin and amylin agonists for treating psychiatric diseases and disorders
|
US20080200383A1
(en)
|
2005-04-08 |
2008-08-21 |
Amylin Pharmaceuticals, Inc. |
Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar Solvent
|
EP1874339A1
(en)
|
2005-04-21 |
2008-01-09 |
Gastrotech Pharma A/S |
Pharmaceutical preparations of a glp-1 molecule and an anti-emetic drug
|
US7569050B2
(en)
|
2005-05-06 |
2009-08-04 |
Medtronic Minimed, Inc. |
Infusion device and method with drive device in infusion device and method with drive device in separable durable housing portion
|
JP5198261B2
(en)
|
2005-06-06 |
2013-05-15 |
カムルス エービー |
GLP-1 analog preparation
|
US20060280795A1
(en)
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
USD565179S1
(en)
*
|
2005-06-16 |
2008-03-25 |
Pentax Corporation |
Bone implant
|
WO2007013957A2
(en)
|
2005-07-22 |
2007-02-01 |
University Of Utah Research Foundation |
Osmotically driven dispense pump and related components for use in high pressure applications
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
EP2330124B1
(en)
|
2005-08-11 |
2015-02-25 |
Amylin Pharmaceuticals, LLC |
Hybrid polypeptides with selectable properties
|
RU2421237C2
(en)
|
2005-08-19 |
2011-06-20 |
Амилин Фармасьютикалз, Инк. |
Methods of diabetes treatment and body weight reduction
|
US8389472B2
(en)
|
2005-08-19 |
2013-03-05 |
Amylin Pharmaceuticals, Llc |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
|
EP1965823B1
(en)
|
2005-11-04 |
2016-05-18 |
Glaxosmithkline LLC |
Methods for administering hypoglycemic agents
|
WO2007053946A1
(en)
|
2005-11-09 |
2007-05-18 |
Conjuchem Biotechnologies Inc. |
Method of treating diabetes and/or obesity with reduced nausea side effects using an insulinotropic peptide conjugated to albumin
|
WO2007075534A2
(en)
|
2005-12-16 |
2007-07-05 |
Nektar Therapeutics Al, Corporation |
Polymer conjugates of glp-1
|
US20090209460A1
(en)
|
2005-12-16 |
2009-08-20 |
Amylin Pharmaceuticals, Inc. |
Compositions and methods for treating obesity and related metabolic disorders
|
ES2397712T3
(en)
|
2006-01-18 |
2013-03-08 |
Qps, Llc |
Pharmaceutical compositions with reinforced stability
|
EP1984063B1
(en)
|
2006-01-19 |
2019-08-14 |
Merck Sharp & Dohme B.V. |
Kit for and method of assembling an applicator for inserting an implant
|
CA2646598C
(en)
|
2006-03-21 |
2014-08-19 |
Amylin Pharmaceuticals, Inc. |
Peptide-peptidase inhibitor conjugates and methods of using same
|
BRPI0711119A2
(en)
|
2006-05-02 |
2011-08-30 |
Actogenix Nv |
microbial administration of obesity-associated intestinal peptides
|
EP2029160A2
(en)
|
2006-05-12 |
2009-03-04 |
Amylin Pharmaceuticals, Inc. |
Methods to restore glycemic control
|
KR101106510B1
(en)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
Two-piece, internal-channel osmotic delivery system flow modulator
|
GB0613196D0
(en)
|
2006-07-03 |
2006-08-09 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
MX2009000434A
(en)
|
2006-07-11 |
2009-01-29 |
Qps Llc |
Pharmaceutical compositions for sustained release delivery of peptides.
|
US8501693B2
(en)
|
2006-08-04 |
2013-08-06 |
Amylin Pharmaceuticals, Llc |
Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen
|
AU2007284759B2
(en)
|
2006-08-09 |
2010-10-28 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
WO2008041246A2
(en)
|
2006-10-05 |
2008-04-10 |
Panacea Biotec Ltd. |
Injectable depot composition and its' process of preparation
|
US8845726B2
(en)
*
|
2006-10-18 |
2014-09-30 |
Vertiflex, Inc. |
Dilator
|
US7632256B2
(en)
|
2006-10-24 |
2009-12-15 |
Mosler Theodore J |
Catheter gripping device
|
WO2008061355A1
(en)
|
2006-11-24 |
2008-05-29 |
Matregen Corp. |
Glp-1 depot systems, and methods of manufacture and uses thereof
|
TWI428346B
(en)
|
2006-12-13 |
2014-03-01 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
RU2477286C2
(en)
|
2007-01-05 |
2013-03-10 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
GLUCAGON ANALOGUES, HAVING HIGH SOLUBILITY IN PHYSIOLOGICAL pH BUFFERS
|
USD555589S1
(en)
*
|
2007-01-23 |
2007-11-20 |
Intec, Inc. |
Battery charger and game controller cradle
|
WO2008092084A2
(en)
|
2007-01-26 |
2008-07-31 |
Centocor, Inc. |
Injectable non-aqueous suspension with high concentration of therapeutic agent
|
EP1958576A3
(en)
*
|
2007-02-13 |
2009-08-05 |
Arthrex Inc |
Double cut shaver
|
US8262667B1
(en)
|
2007-02-23 |
2012-09-11 |
Holmed Corporation |
Multi-diameter implant forceps
|
JP5213950B2
(en)
*
|
2007-04-23 |
2013-06-19 |
エス・アイ・ディ・テクノロジーズ・リミテッド・ライアビリティ・カンパニー |
Method and apparatus for intradermal injection
|
RU2440097C2
(en)
|
2007-04-23 |
2012-01-20 |
Интарсия Терапьютикс, Инк. |
Method of treating insulin-independent diabetes and obesity, osmotic delivery system and method for making it
|
WO2008134425A1
(en)
|
2007-04-27 |
2008-11-06 |
Cedars-Sinai Medical Center |
Use of glp-1 receptor agonists for the treatment of gastrointestinal disorders
|
CN102231981A
(en)
|
2008-02-08 |
2011-11-02 |
昌达生物科技公司 |
Composition for sustained release delivery of proteins or peptides
|
DK2240155T3
(en)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Devices, formulations and methods for the delivery of several beneficial agents
|
AU2009214632B2
(en)
|
2008-02-14 |
2015-02-19 |
Reshape Lifesciences, Inc. |
Treatment of excess weight by neural downregulation in combination with compositions
|
WO2009109927A2
(en)
|
2008-03-05 |
2009-09-11 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
|
US20090234392A1
(en)
*
|
2008-03-13 |
2009-09-17 |
Depuy Spine, Inc. |
Method for inserting a spinal fixation element using implants having guide tabs
|
DK2268299T3
(en)
|
2008-04-01 |
2013-10-07 |
Mosamedix Bv |
Compositions for reducing scarring during wound healing
|
US8483830B2
(en)
|
2008-04-04 |
2013-07-09 |
Enteromedics Inc. |
Methods and systems for glucose regulation
|
US20110263496A1
(en)
|
2008-05-21 |
2011-10-27 |
Amylin Pharmaceuticals, Inc. |
Exendins to lower cholesterol and triglycerides
|
NZ591810A
(en)
|
2008-09-17 |
2012-12-21 |
Chiasma Inc |
Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid
|
CN102202646A
(en)
|
2008-09-30 |
2011-09-28 |
Endo药物方法有限公司 |
Implantable device for the delivery of risperidone and methods of use thereof
|
US9622778B2
(en)
|
2008-10-14 |
2017-04-18 |
Medtronic, Inc. |
Subcutaneous delivery tool
|
NZ592113A
(en)
|
2008-10-15 |
2012-04-27 |
Intarcia Therapeutics Inc |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
WO2010068467A1
(en)
|
2008-11-25 |
2010-06-17 |
Attenuex Technologies, Inc. |
Implant with high vapor pressure medium
|
US20100298840A1
(en)
|
2009-05-22 |
2010-11-25 |
Schwartz Lyman D |
Phimosis Treatment Device and Method
|
USD638478S1
(en)
*
|
2009-07-06 |
2011-05-24 |
Performance Designed Products Llc |
Video game controller accessory
|
US20110022165A1
(en)
*
|
2009-07-23 |
2011-01-27 |
Edwards Lifesciences Corporation |
Introducer for prosthetic heart valve
|
US9358064B2
(en)
|
2009-08-07 |
2016-06-07 |
Ulthera, Inc. |
Handpiece and methods for performing subcutaneous surgery
|
USD791318S1
(en)
*
|
2009-09-14 |
2017-07-04 |
Bayer Oy |
Inserter
|
USD789539S1
(en)
*
|
2015-07-09 |
2017-06-13 |
Spinal Surgical Strategies, Llc |
Fusion cage
|
EP3735944A1
(en)
|
2009-09-28 |
2020-11-11 |
Intarcia Therapeutics, Inc. |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
IT1396771B1
(en)
*
|
2009-10-23 |
2012-12-14 |
Surbone |
GUIDE TUBE FOR A TATTOO MACHINE NEEDLES
|
CN104311657B
(en)
|
2009-12-16 |
2020-12-08 |
诺沃—诺迪斯克有限公司 |
Double acylated GLP-1 derivatives
|
AR079344A1
(en)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
PEPTIDAL ANALOG OF OXINTOMODULIN, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS AND USES TO PREPARE A USEFUL MEDICINAL PRODUCT TO TREAT NON-INSULINED INDEPENDENT DIABETES AND / OR OBESITY
|
AR079345A1
(en)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
OXINTOMODULINE PEPTIDAL ANALOG
|
WO2011156407A2
(en)
|
2010-06-09 |
2011-12-15 |
Amylin Pharmaceuticals, Inc. |
Glp-1 receptor agonists to treat pancre-atitis
|
USD669589S1
(en)
*
|
2010-08-31 |
2012-10-23 |
Koninklijke Philips Electronics N.V. |
Blood system cartridge
|
EP2685938B1
(en)
|
2011-02-14 |
2015-08-26 |
Hyun Bae, M.D. |
System for bone anchor removal
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US8556915B2
(en)
|
2011-05-26 |
2013-10-15 |
Derm Instruments & Innovations Llc |
Skin removal instrument
|
EP2729493B1
(en)
|
2011-07-04 |
2020-06-10 |
IP2IPO Innovations Limited |
Novel compounds and their effects on feeding behaviour
|
WO2013040550A1
(en)
|
2011-09-16 |
2013-03-21 |
Golden Aluminum Company |
Application of designs to portion of food container
|
TWD149032S
(en)
*
|
2011-10-04 |
2012-09-01 |
虹光精密工業股份有限公司 |
Docking for handheld scanner
|
DK2838446T3
(en)
|
2012-04-19 |
2019-01-07 |
Removaid As |
DEVICE FOR REMOVING AN OBJECT IMPLANTED UNDER THE SKIN
|
US9241638B2
(en)
|
2012-05-04 |
2016-01-26 |
Pacesetter, Inc. |
System and method for implanting a physiologic sensor assembly
|
CA2874401A1
(en)
|
2012-05-29 |
2013-12-05 |
National University Corporation Kochi University |
Artery visualization device and artery imaging device
|
US9572970B2
(en)
|
2012-06-04 |
2017-02-21 |
Medtronic, Inc. |
Transcutaneous implant tools, systems and methods
|
USD737972S1
(en)
*
|
2012-06-21 |
2015-09-01 |
Michael Chen |
Tattoo tube grip
|
US20140058425A1
(en)
|
2012-08-27 |
2014-02-27 |
Amir Porat |
Manually operated surgical devices with operative portions formed of a see-through material
|
US9332995B2
(en)
*
|
2012-09-25 |
2016-05-10 |
Russo Inventions, Llc |
Bone-harvesting tool
|
US9241722B2
(en)
*
|
2012-10-08 |
2016-01-26 |
Warsaw Orthopedic, Inc. |
Surgical pin guide and methods of use
|
EP2919764A1
(en)
|
2012-11-19 |
2015-09-23 |
Braeburn Pharmaceuticals BVBA SPRL |
Implantable drug delivery compositions and methods of treatment thereof
|
US9452273B2
(en)
*
|
2012-11-28 |
2016-09-27 |
Richard M. Levitan |
Surgical device for cricothyrotomy and the like
|
US20140324067A1
(en)
*
|
2013-01-09 |
2014-10-30 |
Senseonics, Incorporated |
Subcutaneous tunneling and implantation tools for a disk-shaped sensor
|
US10117645B2
(en)
|
2013-02-19 |
2018-11-06 |
Mark Barongan |
Apparatus for removing devices implanted in the body
|
USD731630S1
(en)
*
|
2014-04-08 |
2015-06-09 |
Bootz Manufacturing Company |
Shower pan
|
USD724740S1
(en)
*
|
2014-06-05 |
2015-03-17 |
Deka Products Limited Partnership |
Enclosure for a peritoneal dialysis device
|
CN106456204B
(en)
|
2014-06-16 |
2019-05-21 |
Med-El电气医疗器械有限公司 |
It is implanted into insertion and the removing tool of magnet
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
USD825761S1
(en)
*
|
2015-04-24 |
2018-08-14 |
Otto Bock Healthcare Products Gmbh |
Part of prosthesis
|
MA44390A
(en)
*
|
2015-06-03 |
2019-01-23 |
Intarcia Therapeutics Inc |
IMPLANT PLACEMENT AND REMOVAL SYSTEMS
|
USD789540S1
(en)
*
|
2016-01-29 |
2017-06-13 |
Veterinary Implants Direct, Llc. |
Orthopedic plate
|
US9931133B2
(en)
*
|
2016-03-24 |
2018-04-03 |
A.M. Surgical, Inc. |
Compact endoscopic surgical device and method of use thereof
|
WO2017200943A1
(en)
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD840030S1
(en)
*
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
US20180193059A1
(en)
*
|
2017-01-10 |
2018-07-12 |
Electronics And Telecommunications Research Institute |
Automatic hair follicle transplant apparatus
|
USD816843S1
(en)
*
|
2017-06-07 |
2018-05-01 |
Alevio, Llc |
Orthopedic implant
|